JOSLIN DIABETES CENTER INC
Reduce your risk when donating: see where the money actually goes.
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text JOSLIN DIABETES CENTER INC. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/joslin-diabetes-center-inc-042203836. Retrieved 2026-11-21.
APA furp.org. (n.d.). JOSLIN DIABETES CENTER INC [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 21, 2026, from https://furp.org/org/joslin-diabetes-center-inc-042203836
MLA “JOSLIN DIABETES CENTER INC.” furp.org, tax years 2009–2024, https://furp.org/org/joslin-diabetes-center-inc-042203836. Accessed 21 Nov. 2026.
Retrieved 2026-11-21; covers tax years 2009–2024. Data: furp.org (index © the FURP Alliance; the records are public domain).
About (Wikipedia)
Joslin Diabetes Center · hospital in Massachusetts, United States
Joslin Diabetes Center is the world's largest diabetes research center, diabetes clinic, and provider of diabetes education. It is located in the Longwood Medical and Academic Area in Boston, Massachusetts, United States.
- Founded
- 1952
- Headquarters
- Boston
- Type
- hospital, research center
- Website
- http://www.joslin.org/
From Wikipedia, CC BY-SA 4.0 (authors and history); facts from Wikidata (CC0). Matched by the same IRS employer identification number (EIN). Report a wrong match · About this data
2024 · Form 990 · revenue $77.3M ($79.3M in 2025 dollars) · expenses $88.2M · assets $182.7M
- EIN
- 04-2203836
- Address
- 1 JOSLIN PL, BOSTON, MA 02215-5306
- Website
- WWW.JOSLIN.ORG
- NTEE code
- G80 Specifically Named Diseases (Voluntary Health Associations and Medical Disciplines) published (IRS Business Master File, as G800)
- FURP topic
- girls boys: boys · girls boys: girls · men: issues · science: research education · women: issues (from its 990 text; the topic index)
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- April 1961 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Hospital or medical research organization
- Cross-check
- ProPublica Nonprofit Explorer
Mission
SEE SCHEDULE O
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
90 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Tabb Md Kevin | CEO (EX-OFF) (CEO, BILH) | 2021-2024 | $4,734,371 | $18,282,737 | 38 |
| Rios Cindy | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | 2022-2024 | $3,594,703 | $6,306,848 | 41 |
| Katz Esq Jamie | CLERK (EX-OFF); BILH GENERAL COUNSEL | 2021-2024 | $1,034,851 | $4,528,976 | 38 |
| Herman Md Phd Roberta | PRESIDENT & TRUSTEE (EX-OFFICIO) | 2013-2024 | $1,010,079 | $3,531,424 | 2 |
| Healy Peter | TTEE (EXO) (DIV PRES, METRO BOSTON) | 2023-2024 | $1,456,880 | $3,139,037 | 15 |
| King Md George L | TTEE EXOFF; SVP CHIEF SCIENTIFIC OFF | 2012-2024 | $515,412 | $2,379,652 | 2 |
| Kahn Md Ronald C | CHIEF ACADEMIC OFFICER | 2021-2024 | $476,219 | $1,896,451 | 2 |
| Aiello Phd Lloyd-Paul | FORMER VICE PRESIDENT, OPTHAMOLOGY | 2021-2024 | $457,023 | $1,782,029 | 1 |
| Sun Md Mph Jennifer K | CHIEF, CENTER EYE RESEARCH & TRIALS | 2023-2024 | $704,350 | $1,155,496 | 1 |
| Lit Susan | CHIEF OPERATING OFFICER | 2022-2024 | $429,347 | $1,146,700 | 2 |
| Mehta Md Sanjeev | TTEE & SVP, CMO, CMIO, CHF QUAL OFF | 2021-2024 | $368,335 | $1,043,416 | 2 |
| Bhogadi Satish | ASST TREAS (EX-OFF) & CFO | 2021-2024 | $334,905 | $960,687 | 3 |
| Sharuk Md George S | OPHTHALMOLOGIST | 2023-2024 | $393,204 | $767,150 | 1 |
| Schlossman Md Deborah | OPHTHALMOLOGIST | 2011-2024 | $348,791 | $656,970 | 1 |
| Williams Md Mark | NEPHROLOGIST | 2011-2024 | $346,452 | $645,835 | 1 |
| Francioli Carl | TREAS EX-OF; BILH INTRM CFO/BSTN CFO | 2024 | $613,611 | $613,611 | 41 |
| Schaffer Md Jean E | SR INVESTIGATOR & ASSOC RESEARCH DIR | 2024 | $331,555 | $331,555 | 1 |
| Mcintire Esq William | ASST CLERK (ASST GEN COUNSEL, BILH) | 2024 | $203,685 | $203,685 | 2 |
| Rowan Michael (former) | TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH | 2021-2023 | $4,703,895 | $8,095,981 | 18 |
| Kahn C Ronald (former) | VICE CHAIR, SECTION CHIEF OBESITY | 2010-2015 | $553,172 | $4,030,219 | 1 |
| Brooks Iii John L (former) | FORMER CEO/PRESIDENT | 2010-2015 | $810,534 | $3,487,830 | 1 |
| Peter S Amenta Md (former) | FORMER PRESIDENT & CEO | 2016-2020 | $272,527 | $3,090,536 | 2 |
| Kerndl John (former) | TREAS (EX-OFF) (EVP & CFO, BILH) | 2021-2022 | $1,335,872 | $2,727,749 | 36 |
| George L King Md (former) | TRUSTEE/SR. VP/CHIEF SCIENCE OFFICER | 2009-2020 | $459,222 | $2,483,047 | 2 |
| Lloyd P Aiello (former) | VICE PRESIDENT, OPHTHALMOLOGY | 2009-2020 | $430,313 | $2,371,164 | 1 |
| Markello Ross J (former) | FORMER CFO/TREASURER | 2011-2015 | $247,595 | $2,360,805 | 5 |
| Robert Gabbay Md Ph D (former) | FORMER CMO & SR. VP | 2016-2020 | $262,960 | $2,303,654 | 1 |
| Abrahamson Martin J (former) | FORMER SR. VP, MED. AFFAIRS | 2010-2015 | $345,978 | $2,114,382 | 1 |
| Maria Buckley (former) | GENERAL COUNSEL | 2012-2020 | $432,394 | $2,038,950 | 4 |
| Eliot Lurier (former) | TREASURER/CFO/COO | 2013-2020 | $463,444 | $2,030,009 | 4 |
| Hamdy Md Mph Osama (former) | PHYS, ENDOCRINE/DIABETES/METABOLISM | 2011-2023 | $362,777 | $1,985,745 | 1 |
| Arrigg Paul G (former) | CHIEF VITREORETINAL SURGURY | 2010-2015 | $321,270 | $1,959,562 | 1 |
| Aiello Lloyd Paul (former) | VICE PRESIDENT, OPHTHALMOLOGY | 2010-2015 | $400,458 | $1,832,954 | 1 |
| King George L Md (former) | TRUSTEE/SR. VP, CSO | 2010-2015 | $393,371 | $1,810,348 | 1 |
| Ronald C Kahn (former) | VICE CHAIRMAN/SECTION CHIEF, OBESITY | 2017-2020 | $457,495 | $1,798,802 | 1 |
| George Sharuk (former) | OPHTHALMOLOGIST | 2009-2020 | $400,259 | $1,796,551 | 1 |
| Paul Arrigg (former) | CHIEF, VITRIORENAL | 2009-2020 | $353,424 | $1,699,302 | 1 |
| Sharuk George S (former) | OPHTHALMOLOGIST | 2010-2014 | $314,985 | $1,644,502 | 1 |
| Buckley Esq Maria D (former) | FORMER CLERK, GENERAL COUNSEL | 2021-2023 | $244,336 | $1,347,995 | 2 |
| Gabbay Robert Md Phd (former) | SR. VP, CMO | 2013-2015 | $464,997 | $1,188,583 | 1 |
| C Ronald Kahn (former) | Vice Chairman/Section Chief, Obesity | 2009-2016 | $552,065 | $1,133,351 | 1 |
| Osama Hamdy (former) | MED. DIR., OBESITY & INPATIENT | 2016-2019 | $363,861 | $1,049,537 | 1 |
| Jennifer Sun (former) | INVESTIGATOR | 2016-2020 | $383,669 | $1,025,790 | 1 |
| Caballero Enrique (former) | MEDICAL ASSOCIATE DIRECTOR | 2013-2015 | $379,026 | $998,483 | 1 |
| Williams Mark E (former) | NEPHROLOGIST | 2013-2015 | $331,395 | $990,887 | 1 |
| Mark Williams (former) | NEPHROLOGIST | 2017-2019 | $333,212 | $966,032 | 1 |
| Lurier Eliot M (former) | FORMER CFO, TREASURER | 2014-2022 | $187,088 | $912,827 | 2 |
| Armstrong Esq Emily (former) | ASST CLERK (DIV VP DEP GC BOS, BILH) | 2021-2023 | $351,216 | $907,882 | 9 |
| Buckley Maria D (former) | GENERAL COUNSEL | 2013-2015 | $314,863 | $899,319 | 1 |
| Chapman John C (former) | GENERAL COUNSEL | 2010-2012 | $299,526 | $811,244 | 1 |
| Ranch Kimball (former) | Former President | 2009 | $769,274 | $769,274 | 2 |
| Quickel Kenneth E (former) | FORMER PRESIDENT AND CEO | 2010 | $703,663 | $703,663 | 1 |
| Deborah Schlossman (former) | OPHTHALMOLOGIST | 2009-2020 | $318,528 | $695,799 | 1 |
| Roberta Herman (former) | PRESIDENT & CHIEF EXECUTIVE OFFICER | 2016-2020 | $678,978 | $678,978 | 4 |
| John A Perry (former) | CHIEF PHILANTHROPY OFFICER | 2016-2017 | $339,684 | $630,265 | 1 |
| Cote Elizabeth R (former) | CHIEF DEVELOPMENT OFFICER | 2021-2022 | $293,155 | $624,295 | 1 |
| John L Brooks Iii (former) | FORMER ceo/president | 2009-2016 | $523,395 | $523,395 | 5 |
| Sanjeev Mehta (former) | VP, CHIEF MED. INFO OFFICER & CQO | 2019-2020 | $261,055 | $476,340 | 2 |
| Kimball Ranch C (former) | FORMER PRESIDENT | 2010 | $388,117 | $388,117 | 1 |
| Aneja Rajni (former) | EXECUTIVE VICE PRESIDENT | 2012 | $383,251 | $383,251 | 1 |
| michael p sullivan (former) | Senior Vice President, Development | 2009 | $378,106 | $378,106 | 1 |
| Sullivan Michael P (former) | SENIOR VICE PRES., DEV. | 2010 | $377,154 | $377,154 | 1 |
| Larrabee Md Joan (former) | PHYS, ENDOCRINE/DIABETES/METABOLISM | 2023 | $373,949 | $373,949 | 1 |
| Arrigg Paul (former) | CHIEF, VITRIORENAL | 2021 | $373,295 | $373,295 | 1 |
| Sun Jennifer (former) | INVESTIGATOR | 2021 | $371,986 | $371,986 | 1 |
| John A Perry Until 22219 (former) | VP, CHIEF PHILANTHROPY OFFICER | 2018 | $371,520 | $371,520 | 1 |
| Halprin Md Elizabeth (former) | SECTION CHIEF, ADULT DIABETES | 2023 | $361,430 | $361,430 | 1 |
| Sharuk George (former) | OPHTHALMOLOGIST | 2021 | $357,408 | $357,408 | 1 |
| Schlossman Deborah K (former) | OPHTHALMOLOGIST | 2010 | $354,411 | $354,411 | 1 |
| Mark Attarian (former) | Former CFO, Treasurer | 2009 | $350,657 | $350,657 | 2 |
| Alicia Peters-Torrey (former) | chief information officer | 2016 | $344,064 | $344,064 | 1 |
| Healy Joseph M (former) | CHIEF STRATEGY OFFICER | 2021 | $342,868 | $342,868 | 1 |
| Elizabeth Cote (former) | CHIEF DEVELOPMENT OFFICER | 2020 | $339,105 | $339,105 | 1 |
| Kenneth E Quickel (former) | President and CEO | 2009 | $329,391 | $329,391 | 1 |
| Martin J Abrahamson (former) | Trustee/Chief Medical Officer | 2009 | $328,170 | $328,170 | 2 |
| Peters-Torrey Alicia (former) | CIO | 2015 | $322,969 | $322,969 | 1 |
| Nandan Padukone (former) | VP, COMMERCIALIZATION & VENTURES | 2017 | $314,663 | $314,663 | 2 |
| Robert Stanton (former) | CHIEF OF NEPHROLOGY | 2019 | $314,162 | $314,162 | 1 |
| D'Errico Matthew (former) | CHIEF INFORMATION OFFICER | 2022 | $305,644 | $305,644 | 1 |
| Harpel Sharon (former) | VP OFFICE SPONSORED RESEARCH | 2022 | $304,487 | $304,487 | 1 |
| Difiore David C (former) | VP CLINICAL SERVICES | 2022 | $260,184 | $260,184 | 1 |
| Markello Ross (former) | CFO, TREASURER | 2010 | $237,555 | $237,555 | 1 |
| O'Donnell Deborah F (former) | DIR, PROJ MGMT & PROCESS IMPROVEMENT | 2022 | $214,751 | $214,751 | 1 |
| howard a wolpert (former) | Trustee/Clinic Physician | 2009 | $209,445 | $209,445 | 1 |
| Attarian Mark A (former) | FORMER CFO, TREASURER | 2010 | $189,385 | $189,385 | 1 |
| allison b goldfine (former) | Trustee/Head of Clinical Research | 2009 | $172,827 | $172,827 | 1 |
| thomas k blackwell (former) | Trustee/Section Head/Inv. | 2009 | $160,824 | $160,824 | 1 |
| Amenta Peter S Md (former) | PRESIDENT/CEO | 2013-2015 | $142,966 | $142,966 | 1 |
| Richard Crater (former) | Former CFO, Treasurer | 2009 | $92,664 | $92,664 | 2 |
| John C Chapman (former) | Clerk | 2009 | $67,576 | $67,576 | 2 |
Officers and directors, no compensation reported
71 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Pasqualini Martin | TRUSTEE & CHAIR | 2021-2024 | 1 | $0 reported | 2 |
| Abbrecht Todd | TRUSTEE | 2021-2024 | 1 | $0 reported | 2 |
| Devlin Michael K | TRUSTEE | 2015-2024 | 1 | $0 reported | 2 |
| Enright Ryan | TRUSTEE | 2023-2024 | 1 | $0 reported | 2 |
| Moses Md Alan | TRUSTEE | 2021-2024 | 1 | $0 reported | 2 |
| Polonsky Md Kenneth | TRUSTEE | 2022-2024 | 1 | $0 reported | 2 |
| Sanna Phd Bastiano | TRUSTEE | 2023-2024 | 1 | $0 reported | 2 |
| Welo Kristen | TRUSTEE | 2021-2024 | 1 | $0 reported | 2 |
| Wing Leverett | TRUSTEE | 2022-2024 | 1 | $0 reported | 2 |
| Yee Shunee | TRUSTEE | 2023-2024 | 1 | $0 reported | 2 |
| Lagasse Anne M | TRUSTEE | 2010-2024 | 1 | $0 reported | 2 |
| Herndon Mba Cpa Fache Scott | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | 2024 | 1 | $0 reported | 40 |
| Bray Christine | TRUSTEE | 2024 | 1 | $0 reported | 2 |
| Meininger Md Gary | TRUSTEE | 2024 | 1 | $0 reported | 2 |
| Rehnert Geoffrey S (former) | TRUSTEE | 2010-2022 | 1 | $0 reported | 3 |
| Peterson James L (former) | TRUSTEE | 2010-2022 | 1 | $0 reported | 2 |
| Russell Mark E (former) | TRUSTEE | 2012-2022 | 1 | $0 reported | 2 |
| Shaheen Stefany (former) | TRUSTEE | 2013-2022 | 1 | $0 reported | 2 |
| Rubenstein Md Arthur (former) | TRUSTEE | 2021 | 1 | $0 reported | 2 |
| James Ralph M (former) | TRUSTEE | 2010-2021 | 1 | $0 reported | 2 |
| Dacey Susan (former) | TRUSTEE | 2021 | 1 | $0 reported | 2 |
| Hopfield Phd Jessica (former) | TRUSTEE | 2013-2021 | 1 | $0 reported | 2 |
| Jessica Hopfield Ph D (former) | TRUSTEE | 2016-2020 | 2 | $0 reported | 1 |
| Todd Abbrecht (former) | TRUSTEE | 2018-2020 | 2 | $0 reported | 1 |
| Michael K Devlin (former) | TRUSTEE | 2016-2020 | 2 | $0 reported | 1 |
| Ralph M James (former) | TRUSTEE | 2009-2020 | 2 | $0 reported | 1 |
| Susan Dacey (former) | TRUSTEE | 2018-2020 | 2 | $0 reported | 1 |
| Ann M Lagasse (former) | TRUSTEE/CHAIR | 2019-2020 | 2 | $0 reported | 1 |
| Martin Pasqualini (former) | TRUSTEE | 2018-2020 | 2 | $0 reported | 1 |
| James L Peterson (former) | TRUSTEE | 2009-2020 | 2 | $0 reported | 1 |
| Geoffrey S Rehnert (former) | TRUSTEE | 2009-2020 | 2 | $0 reported | 1 |
| Arthur Rubenstein Md Mbbch (former) | TRUSTEE | 2016-2020 | 2 | $0 reported | 1 |
| Mark E Russell (former) | TRUSTEE | 2016-2020 | 2 | $0 reported | 1 |
| Stefany Shaheen (former) | TRUSTEE | 2016-2020 | 2 | $0 reported | 2 |
| Richard Smith (former) | TRUSTEE (UNTIL 9/9/20) | 2009-2019 | 2 | $0 reported | 1 |
| Fred Keeton (former) | TRUSTEE | 2016-2018 | 2 | $0 reported | 1 |
| Anne M Lagasse (former) | TRUSTEE | 2009-2018 | 2 | $0 reported | 2 |
| John J Cook Jr (former) | TRUSTEE | 2009-2017 | 2 | $0 reported | 1 |
| Daniel R Omstead Ph D (former) | TRUSTEE | 2016-2017 | 2 | $0 reported | 1 |
| Michele A Whitham Esq (former) | TRUSTEE | 2017 | 2 | $0 reported | 1 |
| Michelle A Whithman Esq (former) | Trustee | 2016 | 2 | $0 reported | 1 |
| Cook Jr John J (former) | TRUSTEE | 2010-2015 | 2 | $0 reported | 1 |
| Geraghty James (former) | TRUSTEE | 2013-2015 | 2 | $0 reported | 1 |
| Keeton Fred (former) | TRUSTEE | 2013-2015 | 2 | $0 reported | 1 |
| Omstead Daniel R Phd (former) | TRUSTEE | 2015 | 2 | $0 reported | 1 |
| Rubenstein Arthur Md Mbbch (former) | TRUSTEE | 2013-2015 | 2 | $0 reported | 1 |
| Smith Richard A (former) | TRUSTEE | 2010-2015 | 2 | $0 reported | 1 |
| Whitman Michelle A Esq (former) | TRUSTEE | 2015 | 2 | $0 reported | 1 |
| Astrue Michael (former) | TRUSTEE | 2013-2014 | 2 | $0 reported | 1 |
| Gardiner Nathaniel S (former) | TRUSTEE | 2010-2014 | 2 | $0 reported | 1 |
| Amenta Md Ph D Peter S (former) | TRUSTEE | 2011-2012 | 2 | $0 reported | 1 |
| Grossman Morella M (former) | TRUSTEE | 2010-2012 | 2 | $0 reported | 1 |
| Allen Walter Ray (former) | TRUSTEE | 2010-2011 | 2 | $0 reported | 1 |
| Mccollough W Alan (former) | TRUSTEE | 2010-2011 | 2 | $0 reported | 1 |
| Amenta Peter S Md Ph D (former) | TRUSTEE | 2010 | 2 | $0 reported | 1 |
| Ross J Markello (former) | CFO, Treasurer | 2009 | 40 | $0 reported | 3 |
| W Ray Allen (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Nathaniel S Gardiner (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Morella Grossmann (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Steven N Kane (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| W Alan McCollough (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| C Richard Carlson (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Don R Conlan (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Kevin E Conley (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Phillip Gorden MD (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Dennis C Guittarr (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Peter H Mattoon (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Robert E Patterson (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| Christopher T Stix (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| J Christine Wilson (former) | Trustee | 2009 | 2 | $0 reported | 1 |
| William T Young Jr (former) | Trustee | 2009 | 2 | $0 reported | 1 |
People by year
2024 · 32 people listed · 18 paid, $17.4M · 499 employees · 12 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| TABB MD KEVIN | CEO (EX-OFF) (CEO, BILH) | 1 | $0 | $3,665,891 | $1,068,480 | $4,734,371 | 38 |
| RIOS CINDY | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | 1 | $0 | $1,386,253 | $2,208,450 | $3,594,703 | 41 |
| HEALY PETER | TTEE (EXO) (DIV PRES, METRO BOSTON) | 1 | $0 | $1,396,570 | $60,310 | $1,456,880 | 15 |
| KATZ ESQ JAMIE | CLERK (EX-OFF); BILH GENERAL COUNSEL | 1 | $0 | $1,001,061 | $33,790 | $1,034,851 | 38 |
| HERMAN MD PHD ROBERTA | PRESIDENT & TRUSTEE (EX-OFFICIO) | 55 | $950,464 | $0 | $59,615 | $1,010,079 | 2 |
| SUN MD MPH JENNIFER K | CHIEF, CENTER EYE RESEARCH & TRIALS | 55 | $650,131 | $0 | $54,219 | $704,350 | 1 |
| FRANCIOLI CARL | TREAS EX-OF; BILH INTRM CFO/BSTN CFO | 1 | $0 | $558,652 | $54,959 | $613,611 | 41 |
| KING MD GEORGE L | TTEE EXOFF; SVP CHIEF SCIENTIFIC OFF | 55 | $453,537 | $0 | $61,875 | $515,412 | 2 |
| KAHN MD RONALD C | CHIEF ACADEMIC OFFICER | 55 | $411,511 | $0 | $64,708 | $476,219 | 2 |
| AIELLO PHD LLOYD-PAUL | FORMER VICE PRESIDENT, OPTHAMOLOGY | 0 | $401,729 | $0 | $55,294 | $457,023 | 1 |
| LIT SUSAN | CHIEF OPERATING OFFICER | 55 | $386,465 | $0 | $42,882 | $429,347 | 2 |
| SHARUK MD GEORGE S | OPHTHALMOLOGIST | 55 | $333,233 | $0 | $59,971 | $393,204 | 1 |
| MEHTA MD SANJEEV | TTEE & SVP, CMO, CMIO, CHF QUAL OFF | 55 | $315,643 | $0 | $52,692 | $368,335 | 2 |
| SCHLOSSMAN MD DEBORAH | OPHTHALMOLOGIST | 55 | $297,251 | $0 | $51,540 | $348,791 | 1 |
| WILLIAMS MD MARK | NEPHROLOGIST | 55 | $291,452 | $0 | $55,000 | $346,452 | 1 |
| BHOGADI SATISH | ASST TREAS (EX-OFF) & CFO | 1 | $0 | $325,132 | $9,773 | $334,905 | 3 |
| SCHAFFER MD JEAN E | SR INVESTIGATOR & ASSOC RESEARCH DIR | 55 | $301,945 | $0 | $29,610 | $331,555 | 1 |
| MCINTIRE ESQ WILLIAM | ASST CLERK (ASST GEN COUNSEL, BILH) | 1 | $0 | $173,112 | $30,573 | $203,685 | 2 |
| PASQUALINI MARTIN | TRUSTEE & CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| ABBRECHT TODD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| BRAY CHRISTINE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DEVLIN MICHAEL K | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ENRIGHT RYAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| LAGASSE ANNE M | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MEININGER MD GARY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MOSES MD ALAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| POLONSKY MD KENNETH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SANNA PHD BASTIANO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WELO KRISTEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WING LEVERETT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| YEE SHUNEE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| HERNDON MBA CPA FACHE SCOTT | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | 1 | $0 | $0 | $0 | $0 | 40 |
2023 · 29 people listed · 19 paid, $20.7M · 407 employees · 10 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| TABB MD KEVIN | CEO (EX-OFF) (CEO, BILH) | 1 | $0 | $4,313,387 | $1,097,028 | $5,410,415 | 38 |
| ROWAN MICHAEL | TTEE(EXO)(CEO DESIG)EVP HOS&AMB BILH | 1 | $0 | $2,302,117 | $2,401,778 | $4,703,895 | 18 |
| RIOS CINDY | TREAS (EX-OFF) (EXEC VP & CFO, BILH) | 1 | $0 | $1,471,427 | $217,736 | $1,689,163 | 41 |
| HEALY PETER | TTEE (EXO) (DIV PRES, METRO BOSTON) | 1 | $0 | $1,597,609 | $84,548 | $1,682,157 | 15 |
| KATZ ESQ JAMIE | CLERK (EX-OFF); GENERAL COUNSEL BILH | 1 | $0 | $1,270,175 | $32,002 | $1,302,177 | 38 |
| HERMAN MD PHD ROBERTA | PRESIDENT & TRUSTEE (EX-OFFICIO) | 55 | $919,763 | $0 | $46,710 | $966,473 | 2 |
| KING MD GEORGE L | TTEE (EX-OFF); CHIEF SCIENTIFIC OFF | 55 | $431,435 | $0 | $59,803 | $491,238 | 2 |
| KAHN MD RONALD C | CHIEF ACADEMIC OFFICER | 55 | $412,111 | $0 | $62,429 | $474,540 | 2 |
| SUN MD MPH JENNIFER K | CHIEF, CENTER EYE RESEARCH & TRIALS | 55 | $398,845 | $0 | $52,301 | $451,146 | 1 |
| AIELLO PHD LLOYD-PAUL | FORMER VICE PRESIDENT, OPTHAMOLOGY | 0 | $388,625 | $0 | $53,432 | $442,057 | 1 |
| LIT SUSAN | CHIEF OPERATING OFFICER | 55 | $324,547 | $0 | $75,035 | $399,582 | 2 |
| LARRABEE MD JOAN | PHYS, ENDOCRINE/DIABETES/METABOLISM | 55 | $313,047 | $0 | $60,902 | $373,949 | 1 |
| SHARUK MD GEORGE S | OPHTHALMOLOGIST | 55 | $315,829 | $0 | $58,117 | $373,946 | 1 |
| HAMDY MD MPH OSAMA | PHYS, ENDOCRINE/DIABETES/METABOLISM | 55 | $301,429 | $0 | $61,348 | $362,777 | 1 |
| HALPRIN MD ELIZABETH | SECTION CHIEF, ADULT DIABETES | 55 | $303,671 | $0 | $57,759 | $361,430 | 1 |
| ARMSTRONG ESQ EMILY | ASST CLERK (DIV VP DEP GC BOS, BILH) | 1 | $0 | $309,666 | $41,550 | $351,216 | 9 |
| MEHTA MD SANJEEV | TTEE & SVP, CMO, CMIO, CHF QUAL OFF | 55 | $288,244 | $0 | $53,019 | $341,263 | 2 |
| BUCKLEY ESQ MARIA D | FORMER CLERK, GENERAL COUNSEL | 0 | $231,268 | $0 | $13,068 | $244,336 | 2 |
| BHOGADI SATISH | ASST TREAS (EX-OFF) & ASSISTANT CFO | 55 | $220,276 | $0 | $11,647 | $231,923 | 3 |
| PASQUALINI MARTIN | TRUSTEE & CHAIR | 1 | $0 | $0 | $0 | $0 | 2 |
| ABBRECHT TODD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DEVLIN MICHAEL K | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ENRIGHT RYAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MOSES MD ALAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| POLONSKY MD KENNETH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SANNA PHD BASTIANO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WELO KRISTEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WING LEVERETT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| YEE SHUNEE | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2022 · 32 people listed · 20 paid, $13.0M · 550 employees · 12 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| TABB MD KEVIN | CEO (EX-OFFICIO) | 1 | $0 | $2,507,235 | $299,917 | $2,807,152 | 38 |
| ROWAN MICHAEL | TRUSTEE (EX-OFFICIO) (CEO DESIGNEE) | 1 | $0 | $1,298,835 | $37,039 | $1,335,874 | 18 |
| KERNDL JOHN | TREAS (EX-OFF) (EVP & CFO, BILH) | 1 | $0 | $1,301,463 | $34,409 | $1,335,872 | 36 |
| RIOS CINDY | TREAS (EX-OFF) (INTERIM CFO, BILH) | 1 | $0 | $802,046 | $220,936 | $1,022,982 | 41 |
| KATZ ESQ JAMIE | CLERK (EX-OFFICIO), GENERAL COUNSEL BILH | 1 | $0 | $898,193 | $15,864 | $914,057 | 38 |
| HERMAN MD PHD ROBERTA | PRESIDENT & TRUSTEE (EX-OFFICIO) | 30 | $757,948 | $0 | $24,643 | $782,591 | 2 |
| BUCKLEY ESQ MARIA D | FORMER CLERK, GENERAL COUNSEL | 0 | $440,860 | $0 | $254,964 | $695,824 | 2 |
| KING MD GEORGE L | TTEE (EX-OFF); CHIEF SCIENTIFIC OFF | 56 | $422,752 | $0 | $57,033 | $479,785 | 2 |
| KAHN MD RONALD C | CHIEF ACADEMIC OFFICER | 55 | $412,206 | $0 | $59,964 | $472,170 | 2 |
| AIELLO PHD LLOYD-PAUL | FORMER VICE PRESIDENT, OPTHAMOLOGY | 55 | $383,800 | $0 | $50,304 | $434,104 | 1 |
| MEHTA MD SANJEEV | TTEE(EX-OFF),SVP,CMO,CMIO, GEN & EPI | 56 | $283,753 | $0 | $50,065 | $333,818 | 2 |
| LIT SUSAN | CHIEF OPERATING OFFICER | 55 | $302,010 | $0 | $15,761 | $317,771 | 2 |
| D'ERRICO MATTHEW | CHIEF INFORMATION OFFICER | 55 | $285,778 | $0 | $19,866 | $305,644 | 1 |
| ARMSTRONG ESQ EMILY | ASST CLERK(EX-OFF), AVP,ASST DEP GC | 1 | $0 | $268,218 | $37,005 | $305,223 | 9 |
| HARPEL SHARON | VP OFFICE SPONSORED RESEARCH | 55 | $275,435 | $0 | $29,052 | $304,487 | 1 |
| COTE ELIZABETH R | CHIEF DEVELOPMENT OFFICER | 55 | $280,302 | $0 | $12,853 | $293,155 | 1 |
| DIFIORE DAVID C | VP CLINICAL SERVICES | 55 | $252,961 | $0 | $7,223 | $260,184 | 1 |
| O'DONNELL DEBORAH F | DIR, PROJ MGMT & PROCESS IMPROVEMENT | 55 | $190,329 | $0 | $24,422 | $214,751 | 1 |
| BHOGADI SATISH | ASST CFO & ASST TREAS (EX-OFF) | 1 | $0 | $180,314 | $14,912 | $195,226 | 3 |
| LURIER ELIOT M | FORMER CFO, TREASURER | 0 | $174,314 | $0 | $12,774 | $187,088 | 2 |
| LAGASSE ANNE M | CHAIR AND TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PASQUALINI MARTIN | VICE CHAIRMAN AND TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ABBRECHT TODD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DEVLIN MICHAEL K | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MOSES ALAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PETERSON JAMES L | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| POLONSKY MD KENNETH | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| RUSSELL MARK E | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SHAHEEN STEFANY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WELO KRISTEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WING LEVERETT | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2021 · 32 people listed · 17 paid, $15.2M · 616 employees · 15 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| TABB MD KEVIN | CEO (EX-OFF); BILH PRES/CEO | 1 | $0 | $5,034,628 | $296,171 | $5,330,799 | 38 |
| ROWAN MICHAEL | TTEE (EX-OFF); BILH EVP, HOSP & AMB | 1 | $0 | $2,019,307 | $36,905 | $2,056,212 | 18 |
| KERNDL JOHN | TREASURER (EX-OFF); BILH EVP & CFO | 1 | $0 | $1,365,000 | $26,877 | $1,391,877 | 36 |
| KATZ ESQ JAMIE | CLERK (EX-OFF); BILH GEN COUNSEL | 1 | $0 | $1,255,848 | $22,043 | $1,277,891 | 38 |
| HERMAN MD PHD ROBERTA | PRES & CEO, TRUSTEE (EX-OFFICIO) | 55 | $715,073 | $0 | $57,208 | $772,281 | 2 |
| KING MD GEORGE L | TRUSTEE, SR. VICE PRESIDENT, CSO | 55 | $433,462 | $0 | $50,524 | $483,986 | 2 |
| KAHN MD RONALD C | CHIEF ACADEMIC OFFICER | 54 | $438,735 | $0 | $34,787 | $473,522 | 2 |
| AIELLO PHD LLOYD-PAUL | FORMER VP, OPTHAMOLOGY | 39 | $401,838 | $0 | $47,007 | $448,845 | 1 |
| BUCKLEY ESQ MARIA D | CLERK, GENERAL COUNSEL | 55 | $373,812 | $0 | $34,023 | $407,835 | 2 |
| ARRIGG PAUL | CHIEF, VITRIORENAL | 40 | $336,610 | $0 | $36,685 | $373,295 | 1 |
| SUN JENNIFER | INVESTIGATOR | 40 | $370,892 | $0 | $1,094 | $371,986 | 1 |
| SHARUK GEORGE | OPHTHALMOLOGIST | 40 | $305,722 | $0 | $51,686 | $357,408 | 1 |
| HEALY JOSEPH M | CHIEF STRATEGY OFFICER | 40 | $339,888 | $0 | $2,980 | $342,868 | 1 |
| LURIER ELIOT M | FORMER CFO, TREASURER | 39 | $304,404 | $0 | $32,637 | $337,041 | 2 |
| COTE ELIZABETH R | CHIEF DEVELOPMENT OFFICER | 40 | $326,482 | $0 | $4,658 | $331,140 | 1 |
| ARMSTRONG ESQ EMILY | ASST CLERK (EX-OFFIC)/VP/DEPUTY GC | 1 | $0 | $213,776 | $37,667 | $251,443 | 9 |
| BHOGADI SATISH | ASST CFO & ASST TREASURER (EX-OFFICIO) | 1 | $0 | $191,687 | $6,946 | $198,633 | 3 |
| ABBRECHT TODD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SHAHEEN STEFANY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| RUSSELL MARK E | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| RUBENSTEIN MD ARTHUR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 3 |
| PETERSON JAMES L | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PASQUALINI MARTIN | VICE CHAIRMAN & TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MOSES ALAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| MEHTA MD SANJEEV | TRUSTEE (EX-OFFICIO) | 1 | $0 | $0 | $0 | $0 | 2 |
| LAGASSE ANNE M | CHAIRMAN AND TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DACEY SUSAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| DEVLIN MICHAEL K | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WELO KRISTEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| HOPFIELD PHD JESSICA | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2020 · 26 people listed · 14 paid, $5.5M · 607 employees · 73 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| ROBERTA HERMAN MD | PRESIDENT & CHIEF EXECUTIVE OFFICER | 39 | $643,492 | $0 | $35,486 | $678,978 | 4 |
| ELIOT M LURIER | TREASURER/CFO/COO | 39 | $410,861 | $0 | $52,583 | $463,444 | 4 |
| GEORGE L KING MD | TRUSTEE/SR. VP/CHIEF SCIENCE OFFICER | 39 | $404,348 | $0 | $54,874 | $459,222 | 2 |
| RONALD C KAHN | VICE CHAIRMAN/SECTION CHIEF, OBESITY | 40 | $409,841 | $0 | $47,654 | $457,495 | 1 |
| MARIA D BUCKLEY | GENERAL COUNSEL | 38 | $383,440 | $0 | $48,954 | $432,394 | 4 |
| LLOYD P AIELLO | VICE PRESIDENT, OPHTHALMOLOGY | 40 | $372,369 | $0 | $57,944 | $430,313 | 1 |
| GEORGE SHARUK | OPHTHALMOLOGIST | 40 | $345,385 | $0 | $54,874 | $400,259 | 1 |
| JENNIFER SUN | INVESTIGATOR | 40 | $359,272 | $0 | $24,397 | $383,669 | 1 |
| PAUL ARRIGG | CHIEF, VITRIORENAL | 40 | $301,841 | $0 | $51,583 | $353,424 | 1 |
| ELIZABETH COTE | CHIEF DEVELOPMENT OFFICER | 40 | $337,111 | $0 | $1,994 | $339,105 | 1 |
| DEBORAH SCHLOSSMAN | OPHTHALMOLOGIST | 40 | $300,230 | $0 | $18,298 | $318,528 | 1 |
| PETER S AMENTA MD | FORMER PRESIDENT & CEO | 0 | $270,879 | $0 | $1,648 | $272,527 | 2 |
| ROBERT GABBAY MD PH D | FORMER CMO & SR. VP | 0 | $238,899 | $0 | $24,061 | $262,960 | 1 |
| SANJEEV MEHTA | VP, CHIEF MED. INFO OFFICER & CQO | 39 | $228,309 | $0 | $32,746 | $261,055 | 2 |
| JESSICA HOPFIELD PH D | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| TODD ABBRECHT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL K DEVLIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RALPH M JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SUSAN DACEY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ANN M LAGASSE | TRUSTEE/CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| MARTIN PASQUALINI | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JAMES L PETERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY S REHNERT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR RUBENSTEIN MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARK E RUSSELL | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEFANY SHAHEEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
2019 · 27 people listed · 13 paid, $5.3M · 643 employees · 219 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PETER S AMENTA MD | PRESIDENT & CEO (UNTIL 12/31/19) | 39 | $716,395 | $0 | $21,355 | $737,750 | 2 |
| ROBERT GABBAY MD PH D | CMO & SR. VP (UNTIL 5/8/20) | 39 | $485,272 | $0 | $50,329 | $535,601 | 1 |
| RONALD C KAHN | VICE CHAIRMAN/SECTION CHIEF, OBESITY | 40 | $395,862 | $0 | $44,911 | $440,773 | 1 |
| GEORGE L KING MD | TRUSTEE/SR. VP/CHIEF SCIENCE OFFICER | 39 | $377,268 | $0 | $50,977 | $428,245 | 2 |
| ELIOT M LURIER | TREASURER/CFO/COO | 39 | $370,315 | $0 | $54,731 | $425,046 | 4 |
| LLOYD P AIELLO | VICE PRESIDENT, OPHTHALMOLOGY | 40 | $363,058 | $0 | $53,521 | $416,579 | 1 |
| MARIA D BUCKLEY | GENERAL COUNSEL | 38 | $353,013 | $0 | $43,667 | $396,680 | 4 |
| OSAMA HAMDY | MED. DIR., OBESITY & INPATIENT | 40 | $312,779 | $0 | $51,082 | $363,861 | 1 |
| MARK WILLIAMS | NEPHROLOGIST | 40 | $290,101 | $0 | $43,111 | $333,212 | 1 |
| GEORGE SHARUK | OPHTHALMOLOGIST | 40 | $277,261 | $0 | $50,977 | $328,238 | 1 |
| JENNIFER SUN | INVESTIGATOR | 40 | $301,492 | $0 | $25,511 | $327,003 | 1 |
| ROBERT STANTON | CHIEF OF NEPHROLOGY | 40 | $261,912 | $0 | $52,250 | $314,162 | 1 |
| SANJEEV MEHTA | VP, CHIEF MEDICAL INFORMATION OFFICER & CQO | 39 | $182,772 | $0 | $32,513 | $215,285 | 2 |
| JESSICA HOPFIELD PH D | TRUSTEE/CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| TODD ABBRECHT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL K DEVLIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RALPH M JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SUSAN DACEY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ANN M LAGASSE | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARTIN PASQUALINI | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JAMES L PETERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY S REHNERT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR RUBENSTEIN MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARK E RUSSELL | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEFANY SHAHEEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| RICHARD SMITH | TRUSTEE (UNTIL 9/9/20) | 2 | $0 | $0 | $0 | $0 | 1 |
| ROBERTA HERMAN MD | PRESIDENT & CHIEF EXECUTIVE OFFICER | 39 | $0 | $0 | $0 | $0 | 4 |
2018 · 27 people listed · 12 paid, $5.0M · 648 employees · 213 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PETER S AMENTA MD | PRESIDENT & CHIEF EXECUTIVE OFFICER | 39 | $701,203 | $0 | $21,080 | $722,283 | 2 |
| ROBERT GABBAY MD PH D | CHIEF MEDICAL OFFICER & SR. VP | 39 | $464,586 | $0 | $50,054 | $514,640 | 1 |
| RONALD C KAHN | VICE CHAIRMAN/SECTION CHIEF, OBESITY | 40 | $394,607 | $0 | $44,884 | $439,491 | 1 |
| GEORGE L KING MD | TRUSTEE/SR. VP/CHIEF SCIENCE OFFICER | 39 | $372,096 | $0 | $50,949 | $423,045 | 2 |
| LLOYD P AIELLO | VICE PRESIDENT, OPHTHALMOLOGY | 40 | $354,742 | $0 | $53,993 | $408,735 | 1 |
| ELIOT M LURIER | TREASURER/CFO/COO | 39 | $354,021 | $0 | $54,703 | $408,724 | 4 |
| MARIA D BUCKLEY | GENERAL COUNSEL | 38 | $341,070 | $0 | $43,356 | $384,426 | 4 |
| JOHN A PERRY UNTIL 22219 | VP, CHIEF PHILANTHROPY OFFICER | 40 | $329,199 | $0 | $42,321 | $371,520 | 1 |
| OSAMA HAMDY | MED. DIR., OBESITY & INPATIENT | 40 | $309,803 | $0 | $52,481 | $362,284 | 1 |
| PAUL G ARRIGG | CHIEF VITREORETINAL SURGERY | 40 | $285,475 | $0 | $52,479 | $337,954 | 1 |
| MARK WILLIAMS | NEPHROLOGIST | 40 | $288,895 | $0 | $43,563 | $332,458 | 1 |
| GEORGE SHARUK | OPHTHALMOLOGIST | 40 | $271,275 | $0 | $50,568 | $321,843 | 1 |
| JESSICA HOPFIELD PH D | TRUSTEE/CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| TODD ABBRECHT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL K DEVLIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ROBERTA HERMAN MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
| RALPH M JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| FRED KEETON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SUSAN DACEY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ANNE M LAGASSE | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| MARTIN PASQUALINI | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JAMES L PETERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY S REHNERT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR RUBENSTEIN MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARK E RUSSELL | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEFANY SHAHEEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| RICHARD A SMITH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2017 · 27 people listed · 12 paid, $4.8M · 664 employees · 246 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| PETER S AMENTA MD | PRESIDENT & CHIEF EXECUTIVE OFFICER | 39 | $678,581 | $0 | $0 | $678,581 | 2 |
| ROBERT GABBAY MD PH D | CHIEF MEDICAL OFFICER & SR. VP | 39 | $454,628 | $0 | $47,307 | $501,935 | 1 |
| RONALD C KAHN | VICE CHAIRMAN/SECTION CHIEF, OBESITY | 40 | $420,075 | $0 | $40,968 | $461,043 | 1 |
| GEORGE L KING MD | TRUSTEE/SR. VP/CHIEF SCIENCE OFFICER | 39 | $371,883 | $0 | $48,209 | $420,092 | 2 |
| LLOYD P AIELLO | VICE PRESIDENT, OPHTHALMOLY | 40 | $355,155 | $0 | $51,426 | $406,581 | 1 |
| ELIOT M LURIER | TREASURER/CFO/COO | 39 | $338,900 | $0 | $51,836 | $390,736 | 4 |
| MARIA D BUCKLEY | GENERAL COUNSEL | 38 | $328,593 | $0 | $40,294 | $368,887 | 4 |
| JOHN A PERRY | CHIEF PHILANTHROPY OFFICER | 40 | $317,356 | $0 | $22,328 | $339,684 | 1 |
| PAUL G ARRIGG | CHIEF VITREORETINAL SURGERY | 40 | $286,070 | $0 | $49,626 | $335,696 | 1 |
| NANDAN PADUKONE | VP, COMMERCIALIZATION & VENTURES | 40 | $265,695 | $0 | $48,968 | $314,663 | 2 |
| GEORGE SHARUK | OPHTHALMOLOGIST | 40 | $264,737 | $0 | $49,247 | $313,984 | 1 |
| MARK WILLIAMS | NEPHROLOGIST | 40 | $260,462 | $0 | $39,900 | $300,362 | 1 |
| JESSICA HOPFIELD PH D | TRUSTEE/CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| JOHN J COOK JR | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHAEL K DEVLIN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ROBERTA HERMAN MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 4 |
| RALPH M JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| FRED KEETON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ANNE M LAGASSE | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| DANIEL R OMSTEAD PH D | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| JAMES L PETERSON | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GEOFFREY S REHNERT | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| ARTHUR RUBENSTEIN MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MARK E RUSSELL | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| STEFANY SHAHEEN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| RICHARD A SMITH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| MICHELE A WHITHAM ESQ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2016 · 28 people listed · 13 paid, $5.3M · 642 employees · 273 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Peter S Amenta md | President & Chief Executive Officer | 39 | $679,395 | $0 | $0 | $679,395 | 2 |
| C Ronald Kahn | Vice Chairman/Section Chief, Obesity | 40 | $511,421 | $0 | $40,644 | $552,065 | 1 |
| John L Brooks III | FORMER ceo/president | 0 | $501,200 | $0 | $22,195 | $523,395 | 5 |
| Robert Gabbay MD Ph D | chief medical officer & sr. vp | 39 | $443,564 | $0 | $44,954 | $488,518 | 1 |
| Lloyd P Aiello | Vice President, Ophthalmology | 40 | $355,903 | $0 | $48,781 | $404,684 | 1 |
| George L King MD | Trustee/Sr. VP/Chief Science Officer | 39 | $353,535 | $0 | $44,752 | $398,287 | 2 |
| Alicia Peters-Torrey | chief information officer | 40 | $335,497 | $0 | $8,567 | $344,064 | 1 |
| Eliot M Lurier | Treasurer/CFO/COO | 39 | $310,530 | $0 | $31,529 | $342,059 | 4 |
| Maria D Buckley | General Counsel | 38 | $300,095 | $0 | $38,486 | $338,581 | 4 |
| Paul G Arrigg | Chief Vitreoretinal Surgery | 40 | $287,009 | $0 | $46,981 | $333,990 | 1 |
| Osama Hamdy | med. dir., obesity & inpatient diab. | 40 | $276,411 | $0 | $46,981 | $323,392 | 1 |
| Jennifer Sun | Investigator | 40 | $292,297 | $0 | $22,821 | $315,118 | 1 |
| John A Perry | Chief Philanthropy Officer | 40 | $272,743 | $0 | $17,838 | $290,581 | 1 |
| Jessica Hopfield Ph D | Trustee/chair | 2 | $0 | $0 | $0 | $0 | 1 |
| John J Cook Jr | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Michael k Devlin | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Roberta Herman MD | Trustee | 2 | $0 | $0 | $0 | $0 | 4 |
| Ralph M James | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Fred Keeton | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Anne M Lagasse | Trustee | 2 | $0 | $0 | $0 | $0 | 2 |
| Daniel R Omstead PH D | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| James L Peterson | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Geoffrey S Rehnert | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Arthur Rubenstein MD MBBCH | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Mark E Russell | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Stefany Shaheen | Trustee | 2 | $0 | $0 | $0 | $0 | 2 |
| Richard A Smith | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Michelle A Whithman Esq | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
2015 · 31 people listed · 15 paid, $5.7M · 694 employees · 143 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| BROOKS III JOHN L | FORMER CEO/PRESIDENT | 0 | $758,875 | $0 | $51,659 | $810,534 | 1 |
| KAHN C RONALD | VICE CHAIR, SECTION CHIEF OBESITY | 40 | $518,475 | $0 | $34,697 | $553,172 | 1 |
| GABBAY ROBERT MD PHD | SR. VP, CMO | 39 | $430,783 | $0 | $34,214 | $464,997 | 1 |
| AIELLO LLOYD PAUL | VICE PRESIDENT, OPHTHALMOLOGY | 40 | $356,886 | $0 | $43,572 | $400,458 | 1 |
| KING GEORGE L MD | TRUSTEE/SR. VP, CSO | 39 | $345,083 | $0 | $48,288 | $393,371 | 1 |
| CABALLERO ENRIQUE | MEDICAL ASSOCIATE DIRECTOR | 40 | $343,448 | $0 | $35,578 | $379,026 | 1 |
| ABRAHAMSON MARTIN J | FORMER SR. VP, MED. AFFAIRS | 0 | $310,283 | $0 | $35,695 | $345,978 | 1 |
| WILLIAMS MARK E | NEPHROLOGIST | 40 | $289,412 | $0 | $41,983 | $331,395 | 1 |
| HAMDY OSAMA | MED. DIR., OBESITY & INPATIENT DIAB. | 40 | $283,216 | $0 | $40,456 | $323,672 | 1 |
| PETERS-TORREY ALICIA | CIO | 40 | $321,798 | $0 | $1,171 | $322,969 | 1 |
| ARRIGG PAUL G | CHIEF VITREORETINAL SURGURY | 40 | $287,923 | $0 | $33,347 | $321,270 | 1 |
| LURIER ELIOT M | CFO/TREASURER | 39 | $290,694 | $0 | $24,897 | $315,591 | 2 |
| BUCKLEY MARIA D | GENERAL COUNSEL | 38 | $278,200 | $0 | $36,663 | $314,863 | 1 |
| MARKELLO ROSS J | FORMER CFO/TREASURER | 0 | $242,740 | $0 | $4,855 | $247,595 | 5 |
| AMENTA PETER S MD | PRESIDENT/CEO | 39 | $142,966 | $0 | $0 | $142,966 | 1 |
| COOK JR JOHN J | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| DEVLIN MICHAEL K | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| GERAGHTY JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| HERMAN ROBERTA MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| HOPFIELD JESSICA PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| KEETON FRED | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| LAGASSE ANNE M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| OMSTEAD DANIEL R PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PETERSON JAMES L | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| RUBENSTEIN ARTHUR MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RUSSELL MARK E | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| SHAHEEN STEFANY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| SMITH RICHARD A | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| WHITMAN MICHELLE A ESQ | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2014 · 27 people listed · 14 paid, $5.4M · 709 employees · 150 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| BROOKS III JOHN L | CEO/PRESIDENT (THRU 9/30/15) | 38 | $695,451 | $0 | $65,288 | $760,739 | 1 |
| MARKELLO ROSS J | FORMER CFO/TREASURER | 0 | $523,015 | $0 | $40,320 | $563,335 | 5 |
| GABBAY ROBERT MD PHD | SR. VP, CMO | 39 | $434,591 | $0 | $47,228 | $481,819 | 1 |
| KAHN C RONALD | VICE CHAIR, SECTION CHIEF OBESITY | 40 | $435,771 | $0 | $41,015 | $476,786 | 1 |
| AIELLO LLOYD PAUL | VICE PRESIDENT, OPHTHALMOLOGY | 40 | $357,003 | $0 | $45,586 | $402,589 | 1 |
| KING GEORGE L MD | TRUSTEE/SR. VP, CSO | 39 | $336,918 | $0 | $40,259 | $377,177 | 1 |
| ABRAHAMSON MARTIN J | FORMER SR. VP, MED. AFFAIRS | 40 | $338,192 | $0 | $37,573 | $375,765 | 1 |
| HAMDY OSAMA | MED. DIR., OBESITY & INPATIENT DIAB. | 40 | $294,567 | $0 | $41,661 | $336,228 | 1 |
| ARRIGG PAUL G | CHIEF VITREORETINAL SURGURY | 40 | $286,669 | $0 | $40,269 | $326,938 | 1 |
| CABALLERO ENRIQUE | MEDICAL ASSOCIATE DIRECTOR | 40 | $280,513 | $0 | $38,994 | $319,507 | 1 |
| WILLIAMS MARK E | NEPHROLOGIST | 40 | $298,515 | $0 | $16,631 | $315,146 | 1 |
| SHARUK GEORGE S | OPHTHALMOLOGIST | 40 | $266,664 | $0 | $48,321 | $314,985 | 1 |
| BUCKLEY MARIA D | GENERAL COUNSEL | 38 | $277,410 | $0 | $19,726 | $297,136 | 1 |
| LURIER ELIOT M | CFO/TREASURER | 39 | $66,642 | $0 | $6,465 | $73,107 | 2 |
| ASTRUE MICHAEL | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| HERMAN ROBERTA MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| HOPFIELD JESSICA PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| KEETON FRED | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RUBENSTEIN ARTHUR MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| COOK JR JOHN J | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GERAGHTY JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| LAGASSE ANNE M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| PETERSON JAMES L | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| RUSSELL MARK E | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| GARDINER NATHANIEL S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2013 · 30 people listed · 13 paid, $5.0M · 692 employees · 117 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| BROOKS III JOHN L | PRESIDENT/CEO | 39 | $681,109 | $0 | $31,479 | $712,588 | 1 |
| MARKELLO ROSS J | CFO/TREASURER | 38 | $485,212 | $0 | $42,676 | $527,888 | 5 |
| KAHN C RONALD | VICE CHAIR, SECTION CHIEF OBESITY | 40 | $484,654 | $0 | $35,548 | $520,202 | 1 |
| AIELLO LLOYD PAUL | DIRECTOR, BEI/INVESTIGATOR | 40 | $361,746 | $0 | $23,898 | $385,644 | 1 |
| KING GEORGE L MD | TRUSTEE/SR. VP, CSO | 39 | $337,842 | $0 | $36,165 | $374,007 | 1 |
| ABRAHAMSON MARTIN J | FORMER SR. VP FOR MEDICAL AFFAIRS | 39 | $310,436 | $0 | $38,676 | $349,112 | 1 |
| HAMDY OSAMA | MED. DIR., OBESITY & INPATIENT DIAB. | 40 | $307,492 | $0 | $40,176 | $347,668 | 1 |
| WILLIAMS MARK E | NEPHROLOGIST | 40 | $322,963 | $0 | $21,383 | $344,346 | 1 |
| ARRIGG PAUL G | CHIEF VITREORETINAL SURGURY | 40 | $285,335 | $0 | $40,176 | $325,511 | 1 |
| SHARUK GEORGE S | OPHTHALMOLOGIST | 40 | $265,098 | $0 | $44,761 | $309,859 | 1 |
| CABALLERO ENRIQUE | MEDICAL ASSOCIATE DIRECTOR | 40 | $260,979 | $0 | $38,971 | $299,950 | 1 |
| BUCKLEY MARIA D | GENERAL COUNSEL | 38 | $271,194 | $0 | $16,126 | $287,320 | 1 |
| GABBAY ROBERT MD PHD | SR. VP, CMO | 39 | $233,309 | $0 | $8,458 | $241,767 | 1 |
| ELIOT LURIER | CHIEF FINANCIAL OFFICER | 39 | $0 | $0 | $0 | $0 | 4 |
| ASTRUE MICHAEL | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| HERMAN ROBERTA MD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| HOPFIELD JESSICA PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| KEETON FRED | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| RUBENSTEIN ARTHUR MD MBBCH | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| COOK JR JOHN J | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| AMENTA PETER S MD PHD | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GARDINER NATHANIEL S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GERAGHTY JAMES | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| LAGASSE ANNE M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| PETERSON JAMES L | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| RUSSELL MARK E | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| SMITH RICHARD A | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| SHAHEEN STEFANY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
2012 · 22 people listed · 12 paid, $4.7M · 699 employees · 115 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| BROOKS III JOHN L | PRESIDENT AND CEO | 39 | $715,913 | $0 | $37,894 | $753,807 | 1 |
| MARKELLO ROSS J | COO & CFO | 39 | $518,809 | $0 | $47,043 | $565,852 | 5 |
| KAHN C RONALD | SECTION CHIEF, OBESITY | 40 | $469,641 | $0 | $40,214 | $509,855 | 1 |
| KING MD GEORGE L | TRUSTEE/SR. VICE PRESIDENT | 40 | $366,255 | $0 | $42,976 | $409,231 | 2 |
| ABRAHAMSON MARTIN J | TRUSTEE/SR. VICE PRESIDENT | 39 | $336,503 | $0 | $49,735 | $386,238 | 1 |
| ANEJA RAJNI | EXECUTIVE VICE PRESIDENT | 40 | $382,581 | $0 | $670 | $383,251 | 1 |
| AIELLO LLOYD PAUL | VP, OPTHALMOLOGY | 40 | $315,457 | $0 | $34,200 | $349,657 | 1 |
| ARRIGG PAUL G | CHIEF VITREORETINAL SURGUR | 40 | $278,911 | $0 | $48,494 | $327,405 | 1 |
| SHARUK GEORGE S | OPHTHALMOLOGIST | 40 | $271,156 | $0 | $55,090 | $326,246 | 1 |
| HAMDY OSAMA | MED. DIR., OBESITY & INPATIENT DIAB. | 40 | $270,676 | $0 | $46,770 | $317,446 | 1 |
| CHAPMAN JOHN C | GENERAL COUNSEL | 39 | $284,943 | $0 | $14,583 | $299,526 | 1 |
| MARIA BUCKLEY | GENERAL COUNSEL | 39 | $112,936 | $0 | $5,046 | $117,982 | 4 |
| COOK JR JOHN J | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| AMENTA MD PH D PETER S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GARDINER NATHANIEL S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GROSSMAN MORELLA M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| LAGASSE ANNE M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| PETERSON JAMES L | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| RUSSELL MARK E | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| SMITH RICHARD A | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2011 · 22 people listed · 11 paid, $4.1M · 706 employees · 136 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| KAHN C RONALD | SECTION CHIEF, OBESITY | 40 | $688,391 | $0 | $21,538 | $709,929 | 1 |
| MARKELLO ROSS J | COO | 40 | $437,098 | $0 | $19,037 | $456,135 | 5 |
| BROOKS III JOHN L | PRESIDENT AND CEO | 40 | $437,726 | $0 | $12,436 | $450,162 | 1 |
| KING GEORGE L | SR. VICE PRESIDENT | 40 | $307,303 | $0 | $36,719 | $344,022 | 1 |
| ABRAHAMSON MARTIN J | TRUSTEE/SR. VICE PRES. | 40 | $282,337 | $0 | $47,238 | $329,575 | 1 |
| ARRIGG PAUL G | CHIEF VITREORETINAL SURGURY | 40 | $276,426 | $0 | $49,867 | $326,293 | 1 |
| SHARUK GEORGE S | OPHTHALMOLOGIST | 40 | $275,405 | $0 | $43,867 | $319,272 | 1 |
| SCHLOSSMAN DEBORAH | OPHTHALMOLOGIST | 40 | $284,124 | $0 | $24,055 | $308,179 | 1 |
| WILLIAMS MARK | NEPHROLOGIST | 40 | $273,477 | $0 | $25,906 | $299,383 | 1 |
| HAMDY OSAMA | MED. DIR., OBESITY & INPATIENT | 40 | $258,734 | $0 | $39,220 | $297,954 | 1 |
| CHAPMAN JOHN C | GNERAL COUNSEL | 40 | $260,312 | $0 | $6,778 | $267,090 | 1 |
| ALLEN WALTER RAY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| COOK JR JOHN J | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| AMENTA MD PH D PETER S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GARDINER NATHANIEL S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GROSSMAN MORELLA M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| LAGASSE ANNE M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| MCCOLLOUGH W ALAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PETERSON JAMES L | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| SMITH RICHARD A | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2010 · 25 people listed · 13 paid, $5.4M · 696 employees · 118 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| KAHN C RONALD | SECTION CHIEF, OBESITY | 40 | $1,211,423 | $0 | $48,852 | $1,260,275 | 1 |
| QUICKEL KENNETH E | FORMER PRESIDENT AND CEO | 40 | $682,259 | $0 | $21,404 | $703,663 | 1 |
| KIMBALL RANCH C | FORMER PRESIDENT | 0 | $388,041 | $0 | $76 | $388,117 | 1 |
| SULLIVAN MICHAEL P | SENIOR VICE PRES., DEV. | 40 | $332,296 | $0 | $44,858 | $377,154 | 1 |
| SHARUK GEORGE S | OPHTHALMOLOGIST | 40 | $326,135 | $0 | $48,005 | $374,140 | 1 |
| SCHLOSSMAN DEBORAH K | OPHTHALMOLOGIST | 40 | $325,437 | $0 | $28,974 | $354,411 | 1 |
| ARRIGG PAUL G | CHIEF VITREORETINAL SURGERY | 40 | $279,086 | $0 | $53,059 | $332,145 | 1 |
| ABRAHAMSON MARTIN J | TRUSTEE/CHIEF MEDICAL OFFI | 40 | $280,062 | $0 | $47,652 | $327,714 | 1 |
| KING GEORGE L | VICE PRESIDENT/CHIEF SCI. OFFICER | 40 | $280,127 | $0 | $41,644 | $321,771 | 1 |
| AIELLO LLOYD PAUL | DIRECTOR, BEI/INVESTIGATOR | 40 | $239,884 | $0 | $54,722 | $294,606 | 1 |
| CHAPMAN JOHN C | CLERK | 40 | $243,202 | $0 | $1,426 | $244,628 | 1 |
| MARKELLO ROSS | CFO, TREASURER | 40 | $224,526 | $0 | $13,029 | $237,555 | 1 |
| ATTARIAN MARK A | FORMER CFO, TREASURER | 40 | $188,682 | $0 | $703 | $189,385 | 1 |
| BROOKS III JOHN L | PRESIDENT AND CEO | 40 | $0 | $0 | $0 | $0 | 1 |
| ALLEN WALTER RAY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| COOK JR JOHN J | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| AMENTA PETER S MD PH D | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GARDINER NATHANIEL S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| GROSSMAN MORELLA M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| LAGASSE ANNE M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| JAMES RALPH M | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| MCCOLLOUGH W ALAN | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PETERSON JAMES L | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 2 |
| REHNERT GEOFFREY S | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 3 |
| SMITH RICHARD A | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
2009 · 39 people listed · 16 paid, $5.2M · 706 employees · 105 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Ranch Kimball | Former President | 40 | $749,094 | $0 | $20,180 | $769,274 | 2 |
| c ronald kahn | Trustee/Vice Chairman/Section chief | 40 | $546,358 | $0 | $34,928 | $581,286 | 1 |
| george s sharuk | Ophthalmologist | 40 | $393,347 | $0 | $38,880 | $432,227 | 1 |
| michael p sullivan | Senior Vice President, Development | 40 | $355,374 | $0 | $22,732 | $378,106 | 1 |
| deborah k schlossman | Ophthalmologist | 40 | $361,407 | $0 | $15,864 | $377,271 | 1 |
| George King | Trustee/Chief Scientific Officer | 40 | $316,933 | $0 | $37,223 | $354,156 | 2 |
| Mark Attarian | Former CFO, Treasurer | 40 | $349,855 | $0 | $802 | $350,657 | 2 |
| Paul G Arrigg | Chief Vitreoretinal Surgery | 40 | $293,998 | $0 | $44,240 | $338,238 | 1 |
| Kenneth E Quickel | President and CEO | 40 | $309,694 | $0 | $19,697 | $329,391 | 1 |
| Martin Abrahamson | Trustee/Chief Medical Officer | 40 | $283,461 | $0 | $44,709 | $328,170 | 2 |
| Lloyd Paul Aiello | Director, BEI/Investigator | 40 | $258,356 | $0 | $45,916 | $304,272 | 1 |
| howard a wolpert | Trustee/Clinic Physician | 40 | $189,451 | $0 | $19,994 | $209,445 | 1 |
| allison b goldfine | Trustee/Head of Clinical Research | 40 | $159,103 | $0 | $13,724 | $172,827 | 1 |
| thomas k blackwell | Trustee/Section Head/Inv. | 40 | $150,130 | $0 | $10,694 | $160,824 | 1 |
| Richard Crater | Former CFO, Treasurer | 40 | $89,690 | $0 | $2,974 | $92,664 | 2 |
| John C Chapman | Clerk | 40 | $67,576 | $0 | $0 | $67,576 | 2 |
| Ross Markello | CFO, Treasurer | 40 | $0 | $0 | $0 | $0 | 3 |
| W Ray Allen | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| John L Brooks III | Trustee (Chairman) | 2 | $0 | $0 | $0 | $0 | 5 |
| John J Cook Jr | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Nathaniel S Gardiner | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Morella Grossmann | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Ralph M James | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Steven N Kane | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Anne M Lagasse | Trustee | 2 | $0 | $0 | $0 | $0 | 2 |
| W Alan McCollough | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| James L Peterson | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Geoffrey S Rehnert | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Richard A Smith | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| C Richard Carlson | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Don R Conlan | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Kevin E Conley | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Phillip Gorden MD | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Dennis C Guittarr | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Peter H Mattoon | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Robert E Patterson | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| Christopher T Stix | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| J Christine Wilson | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
| William T Young Jr | Trustee | 2 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $7.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| BETH ISRAEL LAHEY HEALTH | CHARLESTOWN, MA | MGMT/FIN/LEGAL/HR/OTHER | $5,899,962 |
| BRIGHAM & WOMEN'S HOSPITAL | BOSTON, MA | RESEARCH SERVICES | $639,353 |
| REGENTS OF UNIVERSITY OF MICHIGAN | ANN ARBOR, MI | RESEARCH SERVICES | $567,556 |
| STANFORD UNIVERSITY | REDWOOD CITY, CA | RESEARCH SERVICES | $457,121 |
| CECELIA HEALTH INC | NEW YORK, NY | MEDICAL STAFF SVCS | $327,438 |
2023 · 5 contractors · $3.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| BRIGHAM & WOMEN'S HOSPITAL | BOSTON, MA | RESEARCH | $1,387,330 |
| FISHER SCIENTIFIC | CAMBRIDGE, MA | RESEARCH | $957,460 |
| JACKSON LABORATORY | BAR HARBOR, ME | RESEARCH | $524,480 |
| CHARLES RIVER LABORATORIES | WORCESTER, MA | RESEARCH | $452,340 |
| PLATFORMQ HEALTH EDUCATION LLC | NEEDHAM, MA | DIGITAL EDUCATION SERVICES | $394,180 |
2022 · 5 contractors · $3.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLLIERS INTL NEW ENGLAND | CHICAGO, IL | FACILITY MANAGEMENT | $798,267 |
| BRIGHAM & WOMEN'S HOSP | BOSTON, MA | RESEARCH | $751,715 |
| THE LONGWOOD COLLECTIVE | BOSTON, MA | FACILITY MANAGEMENT | $684,025 |
| PVI PEERVIEW INSTITUTE | NEW YORK, NY | EDUCATIONAL SERVICES | $605,555 |
| NEXTGEN HEALTHCARE INC | ALTANTA, GA | HER SYSTEM SERVICE | $601,473 |
2021 · 5 contractors · $4.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| BETH ISRAEL LAHEY HEALTH INC | BOSTON, MA | MANAGEMENT AND OPERATIONAL SERVICES | $989,017 |
| MASCO SVCS INC | BOSTON, MA | PARKING & CALL CENTER OPERATIONS | $945,848 |
| COLLIERS INTL NEW ENGLAND | CHICAGO, IL | FACILITY MANAGEMENT | $785,837 |
| THE CHARTIS GROUP LLC | CAROL STREAM, IL | CONSULTING SERVICES | $664,700 |
| NEXTGEN HEALTHCARE | HUNT VALLEY, MD | MEDICAL SYSTEM SERVICES | $611,551 |
2020 · 5 contractors · $2.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLLIERS INTERNATIONAL | BOSTON, MA | FACILITIES MANAGEMENT | $826,336 |
| PLATFORMQ HEALTH EDUCATION LLC | NEEDHAM, MA | EDUCATION | $478,002 |
| PRESIDIO NETWORKED SOLUTIONS | PHILADELPHIA, PA | IT SUPPORT & MAINTENANCE | $423,677 |
| REGENTS OF UNIV OF MN | MINNEAPOLIS, MN | RESEARCH | $338,479 |
| ATTAIN LLC | MCLEAN, VA | CONSULTING | $229,533 |
2019 · 5 contractors · $2.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLLIERS INTERNATIONAL | BOSTON, MA | FACILITIES MANAGEMENT | $725,975 |
| REGENTS OF UNIV OF MN | MINNEAPOLIS, MN | RESEARCH | $707,241 |
| PRESIDIO NETWORKED SOLUTIONS | PHILADELPHIA, PA | IT SUPPORT & MAINTENANCE | $589,384 |
| PLATFORMQ HEALTH EDUCATION LLC | NEEDHAM, MA | EDUCATION | $471,368 |
| GRANT THORNTON LLP | BOSTON, MA | AUDIT | $158,384 |
2018 · 5 contractors · $2.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| REGENTS OF UNIV OF MN | MINNEAPOLIS, MN | RESEARCH | $667,451 |
| COLLIERS INTERNATIONAL | BOSTON, MA | FACILITIES MANAGEMENT | $664,199 |
| PLATFORMQ HEALTH EDUCATION LLC | NEEDHAM, MA | EDUCATION | $492,000 |
| PRESIDIO NETWORKED SOLUTIONS | PHILADELPHIA, PA | IT SUPPORT & MAINTENANCE | $211,506 |
| GRANT THORNTON LLP | BOSTON, MA | AUDIT | $149,660 |
2017 · 5 contractors · $2.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| REGENTS OF UNIV OF MN | MINNEAPOLIS, MN | RESEARCH | $840,593 |
| COLLIERS INTERNATIONAL | BOSTON, MA | FACILITIES MANAGEMENT | $779,564 |
| PLATFORMQ HEALTH EDUCATION LLC | NEEDHAM, MA | EDUCATION | $592,900 |
| RPI CONSULTANTS | BALTIMORE, MD | ERP IMPLEMENTATION | $255,409 |
| KENYA MOUNTAIN LLC | DUNSTABLE, MA | IT CONSULTANT | $119,955 |
2016 · 5 contractors · $1.4M
| Name | Location | Service | Paid |
|---|---|---|---|
| COLLIERS INTERNATIONAL | BOSTON, MA | FACILITIES Management | $688,754 |
| ATTAIN LLC | MCLEAN, VA | BUSINESS Management services | $223,442 |
| RPI CONSULTANTS | BALTIMORE, MD | ERP IMPLEMENTATION | $158,859 |
| PIERCE ATWOOD | PORTLAND, ME | LEGAL | $153,636 |
| KENYA MOUNTAIN | DUNSTABLE, MA | IT NETWORK Services | $147,511 |
2015 · 5 contractors · $1.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| MARK D CRAWFORD | BILLERICA, MA | ARCHITECTURAL | $325,399 |
| PIERCE ATWOOD | PORTSMOUTH, NH | LEGAL | $253,794 |
| COMMONWEALTH CREATIVE ASSOCIATES INC | FRAMINGHAM, MA | MARKETING | $253,440 |
| DAVINCI DIRECTINC | PLYMOUTH, MA | MARKETING | $252,286 |
| PROVIDENCE HEALTH FOUNDATION | WASHINGTON, DC | RESEARCH | $148,649 |
2014 · 5 contractors · $2.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| BETH ISRAEL DEACONESS MEDICAL CENTER | BOSTON, MA | CLINICAL SERVICES | $892,009 |
| MARK D CRAWFORD | BILLERICA, MA | ARCHITECTURAL | $411,839 |
| DAVINCI DIRECT INC | PLYMOUTH, MA | FUNDRAISING | $385,652 |
| PIERCE ATWOOD | BOSTON, MA | LEGAL | $294,462 |
| HARVARD MEDICAL FACULTY PHYSICIANS | BOSTON, MA | HEALTH CARE PROFESSIONAL | $228,661 |
2013 · 5 contractors · $2.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| BETH ISRAEL DEACONESS MEDICAL CENTER | CLINICAL SERVICES | $830,443 | |
| MARK D CRAWFORD | ARCHITECTURAL | $739,135 | |
| PIERCE ATWOOD | LEGAL | $484,787 | |
| PROVIDENCE HEALTH FOUNDATION | PERSONNEL | $351,632 | |
| KORNFERRY INTERNATIONAL | PROFESSIONAL | $339,380 |
2012 · 5 contractors · $2.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| MARK D CRAWFORD | BILLERICA, MA | ARCHITECTURAL | $902,299 |
| PIERCE ATWOOD | BOSTON, MA | LEGAL | $554,349 |
| DUANE MORRIS LLP | BOSTON, MA | LEGAL | $229,051 |
| INTEGRATED LEARNING PARTNERS | WESTPORT, CT | MANAGEMENT CONSULTING | $212,082 |
| VICTOR SOLOD | BENNINGTON, NH | ELECTRICAL | $209,364 |
2011 · 5 contractors · $2.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| MARK D CRAWFORD | BILLERICA, MA | ARCHITECHURAL | $652,400 |
| PIERCE ATWOOD | BOSTON, MA | LEGAL | $550,262 |
| NEWPORT CREATIVE COMM | DUXBURY, MA | DIRECT MAIL | $408,988 |
| AMERICAN CLEANING CP INC | CAMBRIDGE, MA | JANITORIAL | $248,826 |
| VICTOR SOLOD | BENNINGTON, NH | ELECTRICAL | $227,932 |
2010 · 5 contractors · $1.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| MARK D CRAWFORD | BILLERICA, MA | GENERAL CONTRACTOR | $504,864 |
| DELOITTE & TOUCHE LLP | BOSTON, MA | PUBLIC ACCOUNTANTS | $373,595 |
| LIFE TECHNOLOGIES | CHICAGO, IL | BIOTECHNOLOGY TOOLS | $324,924 |
| ATTAIN LLC | CHANTILLY, VA | PROFESSIONAL SERVICES | $310,081 |
| HARRIS CONNECT LLC | BREWSTER, NY | PROFESSIONAL SERVICES | $297,528 |
2009 · 5 contractors · $2.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| tatum llc | atlanta, GA | executive compensation cons. | $698,093 |
| mckinsey & company | boston, MA | management consultants | $375,000 |
| deloitte & touche | boston, MA | public accountants | $350,640 |
| mintz levin cohn ferris glovsky | boston, MA | legal services | $348,957 |
| stax inc | boston, MA | management consultants | $345,000 |
Paid as a vendor by
Other organizations that listed this one among their highest-paid independent contractors. Contractor lists give no EIN, so these are matched on name and address; check the filing.
| Year | Paid by | Service | Paid | Filing |
|---|---|---|---|---|
| 2023 | JAEB CENTER FOR HEALTH RESEARCH INC | PATIENT-FACING RESEARCH SERVICES | $567,000 | view vendor page |
| 2020 | HEALTHPARTNERS INSTITUTE | CONSULTING | $477,119 | view vendor page |
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 23 grants to organizations · $11.1M
2023 · 16 grants to organizations · $9.6M
2022 · 18 grants to organizations · $11.4M
2021 · 29 grants to organizations · $15.2M
2020 · 1 grant to organizations · $10.1M
2019 · 1 grant to organizations · $14.8M
2018 · 1 grant to organizations · $10.4M
2017 · 1 grant to organizations · $9.9M
2016 · 1 grant to organizations · $8.2M
2015 · 1 grant to organizations · $8.1M
2014 · 1 grant to organizations · $9.0M
2013 · 1 grant to organizations · $7.0M
2012 · 1 grant to organizations · $6.2M
2011 · 1 grant to organizations · $5.4M
2010 · 1 grant to organizations · $4.8M
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $77,259,482 | $88,177,463 | $182,656,365 | $168,689,929 | $37,163,837 | $36,227,356 | $2,799,392 | 499 | 12 |
| 2023 · Form 990 | ||||||||
| $71,591,609 | $81,626,334 | $176,840,438 | $160,608,284 | $35,828,689 | $31,596,388 | $2,596,376 | 407 | 10 |
| 2022 · Form 990 | ||||||||
| $74,197,360 | $82,769,482 | $166,005,908 | $154,014,521 | $37,640,010 | $34,027,420 | $2,386,134 | 550 | 12 |
| 2021 · Form 990 | ||||||||
| $134,166,466 | $98,047,633 | $158,601,430 | $146,105,200 | $41,138,916 | $38,826,007 | $2,137,624 | 616 | 15 |
| 2020 · Form 990 | ||||||||
| $81,813,666 | $90,420,592 | $119,817,710 | $82,507,784 | $40,035,593 | $38,387,179 | $2,871,597 | 607 | 73 |
| 2019 · Form 990 | ||||||||
| $76,953,905 | $96,451,661 | $107,556,453 | $78,228,399 | $33,046,867 | $40,609,412 | $3,434,512 | 643 | 219 |
| 2018 · Form 990 | ||||||||
| $80,200,703 | $94,714,085 | $116,544,681 | $93,755,336 | $35,866,710 | $41,465,936 | $4,558,607 | 648 | 213 |
| 2017 · Form 990 | ||||||||
| $98,325,080 | $91,783,272 | $129,902,651 | $108,867,829 | $55,435,185 | $40,819,240 | $1,505,092 | 664 | 246 |
| 2016 · Form 990 | ||||||||
| $88,049,280 | $88,501,958 | $121,882,330 | $96,100,424 | $44,232,822 | $40,979,789 | $1,768,791 | 642 | 273 |
| 2015 · Form 990 | ||||||||
| $85,159,175 | $93,080,038 | $128,407,040 | $96,393,088 | $40,370,530 | $42,547,278 | $5,138,337 | 694 | 143 |
| 2014 · Form 990 | ||||||||
| $83,768,922 | $95,799,796 | $134,552,270 | $100,177,124 | $35,993,445 | $44,978,158 | $4,981,203 | 709 | 150 |
| 2013 · Form 990 | ||||||||
| $100,951,725 | $95,699,704 | $144,264,386 | $115,834,374 | $45,974,663 | $45,490,953 | $3,448,373 | 692 | 117 |
| 2012 · Form 990 | ||||||||
| $95,705,404 | $92,662,914 | $137,096,256 | $109,889,799 | $38,942,913 | $44,922,618 | $3,032,423 | 699 | 115 |
| 2011 · Form 990 | ||||||||
| $94,239,533 | $89,954,142 | $135,879,420 | $105,706,842 | $41,682,623 | $45,874,496 | $2,205,579 | 706 | 136 |
| 2010 · Form 990 | ||||||||
| $85,576,459 | $85,455,938 | $127,648,830 | $94,317,899 | $39,447,164 | $40,533,855 | $5,077,263 | 696 | 118 |
| 2009 · Form 990 | ||||||||
| $81,211,016 | $96,356,934 | $136,074,590 | $100,480,038 | $36,244,094 | $39,664,322 | $3,403,351 | 706 | 105 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- JOSLIN CLINIC INC Charlestown, MA · 26 people in common (Abbrecht Todd, Bhogadi Satish, Bray Christine)
- BETH ISRAEL DEACONESS MEDICAL CENTER INC Boston, MA · 7 people in common (Bhogadi Satish, Francioli Carl, Healy Peter) · related organization (Schedule R)
- BETH ISRAEL LAHEY HEALTH INC HCSR Cambridge, MA · 6 people in common (Francioli Carl, Healy Peter, Herndon Mba Cpa Fache Scott) · related organization (Schedule R)
- MOUNT AUBURN HOSPITAL Cambridge, MA · 6 people in common (Francioli Carl, Healy Peter, Herndon Mba Cpa Fache Scott)
- NEW ENGLAND BAPTIST HOSPITAL Boston, MA · 6 people in common (Francioli Carl, Healy Peter, Herndon Mba Cpa Fache Scott)
- BETH ISRAEL DEACONESS HOSPITAL- MILTON INC Milton, MA · 6 people in common (Francioli Carl, Healy Peter, Herndon Mba Cpa Fache Scott) · related organization (Schedule R)
- BID-MILTON PHYSICIAN ASSOCIATES INC Charlestown, MA · 6 people in common (Francioli Carl, Healy Peter, Herndon Mba Cpa Fache Scott)
- COMMUNITY PHYSICIANS ASSOCIATES INC Milton, MA · 6 people in common (Francioli Carl, Healy Peter, Herndon Mba Cpa Fache Scott)
- LAHEY CLINIC HOSPITAL INC Burlington, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie) · related organization (Schedule R)
- NORTHEAST HOSPITAL CORPORATION Beverly, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- WINCHESTER HOSPITAL Winchester, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie) · related organization (Schedule R)
- ANNA JAQUES HOSPITAL Newburyport, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- NORTHEAST BEHAVIORAL HEALTH CORPORATION Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- JORDAN PHYSICIAN ASSOCIATES INC Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- LAHEY CLINIC FOUNDATION INC Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- NORTHEAST SENIOR HEALTH CORPORATION Beverly, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- JORDAN HEALTH SYSTEMS INC Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- SEACOAST NURSING AND REHABILITATION CENTER INC Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- LAHEY HEALTH SHARED SERVICES INC Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
- CAB HEALTH AND RECOVERY SERVICES INC Charlestown, MA · 5 people in common (Francioli Carl, Herndon Mba Cpa Fache Scott, Katz Esq Jamie)
Funders of this organization
250 grantors reported grants to this organization, $99,555,352 in all, tax years 2009 to 2025; the 25 largest shown (all 250). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Total given | Grants | Latest year's amount | Latest year | Years given | Type | Match | Grants |
|---|---|---|---|---|---|---|---|---|
| BREAKTHROUGH T1D | $30,442,071 | 16 | $2,565,662 | 2024 | 2009-2010, 2012-2024 | Public charity | Exact | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | $9,294,440 | 9 | $369,048 | 2024 | 2016-2024 | DAF sponsor | Exact | show |
| PRESIDENT AND FELLOWS OF HARVARD COLLEGE | $6,868,512 | 15 | $582,563 | 2024 | 2009-2022, 2024 | DAF sponsor | Exact | show |
| American Diabetes Association Research Foundation Inc | $6,720,546 | 43 | $433,850 | 2021 | 2010-2016, 2018, 2020-2021 | Public charity | Exact | show |
| BROAD INSTITUTE INC | $5,209,632 | 12 | $1,565,106 | 2024 | 2013-2024 | Public charity | Exact | show |
| BETH ISRAEL DEACONESS MEDICAL CENTER INC | $4,687,016 | 17 | $131,577 | 2024 | 2009-2024 | Public charity | Exact | show |
| LEGACY GLOBAL FOUNDATION INC | $3,069,473 | 3 | $2,799,475 | 2021 | 2019-2021 | Public charity | Exact | show |
| LEONA M & HARRY B HELMSLEY CHARITABLE TRUST | $2,838,609 | 5 | $569,990 | 2024 | 2020-2021, 2023-2024 | Private foundation | Fuzzy filed as “JOSLIN DIABETES CENTER INC” | show |
| GEORGE WASHINGTON UNIVERSITY | $2,086,247 | 11 | $174,367 | 2024 | 2011, 2015-2024 | Public charity | Exact | show |
| RAYMOND JAMES CHARITABLE ENDOWMENT FUND | $1,517,250 | 7 | $254,000 | 2024 | 2016-2017, 2019-2021, 2023-2024 | DAF sponsor | Exact | show |
| AMERICAN HEART ASSOCIATION INC | $1,502,414 | 7 | $156,640 | 2024 | 2014, 2018-2019, 2021-2024 | Public charity | Exact | show |
| CHAN ZUCKERBERG INITIATIVE FOUNDATION | $1,499,835 | 3 | $561,278 | 2021 | 2019-2021 | Private foundation | Fuzzy filed as “Joslin Diabetes Center Inc”, “JOSLIN DIABETES CENTER INC” | show |
| BOSTON MEDICAL CENTER CORPORATION | $1,012,836 | 13 | $303,002 | 2024 | 2009-2011, 2013, 2015-2017, 2019-2024 | Public charity | Exact | show |
| UNIVERSITY OF CHICAGO | $1,007,170 | 5 | $27,370 | 2024 | 2020-2024 | Public charity | Exact | show |
| YALE UNIVERSITY | $931,641 | 6 | $156,217 | 2021 | 2015, 2017-2021 | DAF sponsor | Exact | show |
| STEVEN M & JOYCE E TADLER CHARITABLE TR | $890,000 | 10 | $100,000 | 2024 | 2012, 2014-2015, 2018-2024 | Private foundation | Fuzzy filed as “JOSLIN DIABETES CENTER” | show |
| FORGOOD INC | $845,657 | 6 | $11,511 | 2019 | 2014-2019 | DAF sponsor | Exact | show |
| AMERICAN DIABETES ASSOCIATION INC | $706,324 | 8 | $211,068 | 2024 | 2022-2024 | DAF sponsor | Exact | show |
| MASSACHUSETTS LIONS EYE RESEARCH FUND INC | $701,000 | 5 | $138,000 | 2024 | 2020-2024 | Public charity | Fuzzy filed as “JOSLIN DIABETES CENTER” | show |
| CHILDRENS MERCY HOSPITAL | $678,615 | 5 | $54,288 | 2023 | 2018-2019, 2021-2023 | Public charity | Exact | show |
| DONOR ADVISED CHARITABLE GIVING | $667,285 | 12 | $323,878 | 2024 | 2014-2024 | DAF sponsor | Exact | show |
| EDWIN S WEBSTER FOUNDATION | $660,000 | 16 | $50,000 | 2025 | 2010-2025 | Private foundation | Fuzzy filed as “JOSLIN DIABETES CENTER” | show |
| HAROLD & REBECCA GROSS FDN TUW | $640,000 | 11 | $60,000 | 2024 | 2014-2024 | Private foundation | Fuzzy filed as “JOSLIN DIABETES CENTER” | show |
| REESE FAM CHARITABLE FO II | $500,000 | 3 | $82,750 | 2018 | 2015-2016, 2018 | Private foundation | Fuzzy filed as “Joslin Diabetes Center” | show |
| PEABODY FOUNDATION INC | $500,000 | 7 | $50,000 | 2016 | 2009, 2011-2016 | Private foundation | Fuzzy filed as “JOSLIN DIABETES CENTER” | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. NTEE: the IRS’s code when it lists one, otherwise FURP’s inferred code. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| AMERICAN DIABETES ASSOCIATION INC | VA | G80 | $152,241,578 | $132,618,849 | Chief Executive Officer | $1,287,811 | Same NTEE code G80, revenue within 2x |
| FUND FOR PUBLIC HEALTH IN NEW YORK INC | NY | G80 | $98,316,171 | $87,656,289 | CEO UNTIL 7/10/26 | $310,071 | Same NTEE code G80, revenue within 2x |
| MAKE- A- WISH FOUNDATION OF AMERICA | AZ | G80 | $136,767,956 | $137,816,534 | PRESIDENT & CEO | $739,620 | Same NTEE code G80, revenue within 2x |
| THE RARE DISEASE CHARITABLE FOUNDATION | MA | G80 | $162,843,174 | $171,314,161 | Chair | $0 | Same NTEE code G80, revenue within 5x, same state |
| HEMOSTASIS AND THROMBOSIS CENTER OF NEVADA | NV | G80 | $28,961,379 | $24,383,488 | EXECUTIVE DI | $230,764 | Same NTEE code G80, revenue within 5x |
| BREAKTHROUGH T1D | NY | G80 | $301,723,973 | $281,012,901 | CHIEF EXECUTIVE OFFICER | $1,048,752 | Same NTEE code G80, revenue within 5x |
| CHILDRENS AUTISM CENTERINCORPORATED | IN | G80 | $10,232,383 | $13,735,642 | COO | $111,493 | Same NTEE code G80, revenue within 10x |
| MALARIA CONSORTIUM US INC | PA | G80 | $10,418,949 | $9,557,028 | TRUSTEE | $0 | Same NTEE code G80, revenue within 10x |
| EB RESEARCH PARTNERSHIP INC | NY | G80 | $8,244,493 | $6,577,859 | CEO | $483,555 | Same NTEE code G80, revenue within 10x |
| LYMPHOMA RESEARCH FOUNDATION | NY | G80 | $14,181,182 | $14,306,630 | CHIEF EXECUTIVE OFFICER | $382,766 | Same NTEE code G80, revenue within 10x |
| PRION ALLIANCE INC | MA | G80 | $635,871 | $423,280 | PRESIDENT | $0 | Same NTEE code G80, revenue differs more than 10x, same state, similar mission |
| COLLEGE DIABETES NETWORK INC | MA | G80 | $2,133,964 | $2,223,678 | INTERIM CEO (THRU 12/31/24)/DIRECTOR | $221,515 | Same NTEE code G80, revenue differs more than 10x, same state |
| INTERNATIONAL ALLIANCE FOR DIABETES ACTION | MA | G80 | $630,356 | $554,192 | PROGRAM AND COMMUNITY MANAGER | $101,727 | Same NTEE code G80, revenue differs more than 10x, same state |
| FOUNDATION FOR CELIAC DISEASE OUTCOME MEASURES INC | MA | G80 | $153,410 | $98,202 | PRESIDENT | $0 | Same NTEE code G80, revenue differs more than 10x, same state |
| DYSLIPIDEMIA FOUNDATION INC | MA | G80 | $193,947 | $175,293 | Director | $0 | Same NTEE code G80, revenue differs more than 10x, same state |
| ALD CONNECT INC | MA | G80 | $982,449 | $780,119 | EXECUTIVE DIRECTOR | $128,606 | Same NTEE code G80, revenue differs more than 10x, same state |
| MITOACTION INC | MA | G80 | $416,574 | $503,315 | CEO | $111,765 | Same NTEE code G80, revenue differs more than 10x, same state |
| MASSACHUSETTS ME-CFS & FM ASSOCIATION INC | MA | G80 | $84,263 | $90,706 | President | $0 | Same NTEE code G80, revenue differs more than 10x, same state |
| WAKE UP NARCOLEPSY INC | MA | G80 | $1,370,014 | $1,374,620 | Executive Director | $60,125 | Same NTEE code G80, revenue differs more than 10x, same state |
| MALS PALS | MA | G80 | $57,355 | $44,348 | President | $0 | Same NTEE code G80, revenue differs more than 10x, same state |
| SCORE POWER TRAINING FOR PARKINSONS | MA | G80 | $59,580 | $47,585 | PRESIDENT | $0 | Same NTEE code G80, revenue differs more than 10x, same state |
| AISLINNS WISH FOUNDATION | NC | G80 | $73,872 | $73,919 | PRESIDENT | $0 | Same NTEE code G80, revenue differs more than 10x, similar mission |
| DIABETES INCORPORATED | SD | G80 | $96,301 | $67,718 | MEMBER AT LARGE | $0 | Same NTEE code G80, revenue differs more than 10x, similar mission |
| KENTUCKY DIABETES NETWORK INC | KY | G80 | $70,767 | $28,045 | Chairperson | $0 | Same NTEE code G80, revenue differs more than 10x |
| DIABETES SOLUTIONS OK INC | OK | G80 | $197,322 | $275,762 | Executive Dir. | $55,087 | Same NTEE code G80, revenue differs more than 10x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $88,177,463 spent · pay $27,893,777 · grants $11,078,365 · events $705,582
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MISC PURCHASED SERVICES | $22,046,954 | $14,664,116 | $7,382,838 | - | 25.0% |
| Other salaries and wages | $15,145,302 | $12,731,773 | $2,413,529 | - | 17.2% | |
| Grants to US organizations and governments | $11,078,365 | $11,078,365 | - | - | 12.6% | |
| Other employee benefits | $6,874,135 | $5,778,685 | $1,095,450 | - | 7.8% | |
| Other (as described) | SUPPLIES | $6,261,299 | $6,221,856 | $39,443 | - | 7.1% |
| Depreciation and depletion | $5,536,047 | $3,331,275 | $2,204,772 | - | 6.3% | |
| Fees: management | $5,514,888 | $4,136,166 | $1,363,556 | $15,166 | 6.3% | |
| Office expenses | $4,599,348 | $4,059,906 | $539,442 | - | 5.2% | |
| Occupancy | $3,185,297 | $2,015,339 | $1,169,958 | - | 3.6% | |
| Pay: officers, directors, trustees, key employees | $2,799,392 | $2,353,285 | $446,107 | - | 3.2% | |
| Payroll taxes | $1,768,964 | $1,487,065 | $281,899 | - | 2.0% | |
| Pension plan contributions | $848,961 | $713,672 | $135,289 | - | 1.0% | |
| Fees: investment management | $603,523 | - | $603,523 | - | 0.7% | |
| Pay: disqualified persons | $457,023 | $384,193 | $72,830 | - | 0.5% | |
| Travel | $409,690 | $392,780 | $16,910 | - | 0.5% | |
| Other (as described) | PATIENT SUBJECT COSTS | $343,367 | $343,367 | - | - | 0.4% |
| Fees: legal | $286,006 | $230,634 | $55,372 | - | 0.3% | |
| Insurance | $197,970 | $185,176 | $12,794 | - | 0.2% | |
| Conferences, conventions and meetings | $136,950 | $121,940 | $15,010 | - | 0.2% | |
| Information technology | $51,604 | $40,011 | $11,593 | - | 0.1% | |
| Other (as described) | PRINTING & PUBLICATION | $31,563 | $31,563 | - | - | 0.0% |
| Fees: accounting | $815 | - | $815 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $169,688 | $568,632 | reported apart | |||
| Total | $88,177,463 | 100% |
2023 · Form 990 · $81,626,334 spent · pay $28,961,161 · grants $9,608,581 · events $620,451
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MISC PURCHASED SERVICES | $25,962,370 | $18,461,564 | $7,500,806 | - | 31.8% |
| Other salaries and wages | $16,374,866 | $13,799,785 | $2,575,081 | - | 20.1% | |
| Grants to US organizations and governments | $9,608,581 | $9,608,581 | - | - | 11.8% | |
| Other employee benefits | $6,679,778 | $5,629,329 | $1,050,449 | - | 8.2% | |
| Depreciation and depletion | $5,657,540 | $3,355,664 | $2,220,914 | $80,962 | 6.9% | |
| Other (as described) | SUPPLIES | $4,923,938 | $4,891,406 | $32,532 | - | 6.0% |
| Occupancy | $2,922,162 | $1,834,628 | $1,043,270 | $44,264 | 3.6% | |
| Pay: officers, directors, trustees, key employees | $2,596,376 | $2,188,075 | $408,301 | - | 3.2% | |
| Payroll taxes | $1,802,297 | $1,518,871 | $283,426 | - | 2.2% | |
| Office expenses | $1,378,949 | $404,073 | $973,635 | $1,241 | 1.7% | |
| Pension plan contributions | $887,951 | $748,314 | $139,637 | - | 1.1% | |
| Pay: disqualified persons | $619,893 | $522,410 | $97,483 | - | 0.8% | |
| Fees: investment management | $518,284 | - | $518,284 | - | 0.6% | |
| Travel | $479,266 | $460,981 | $18,114 | $171 | 0.6% | |
| Insurance | $452,359 | $215,853 | $236,506 | - | 0.6% | |
| Fees: legal | $310,883 | $310,883 | - | - | 0.4% | |
| Conferences, conventions and meetings | $225,386 | $206,417 | $18,969 | - | 0.3% | |
| Fees: professional fundraisers | $141,250 | - | - | $141,250 | 0.2% | |
| Information technology | $44,753 | $31,161 | $13,592 | - | 0.1% | |
| Other (as described) | PRINTING & PUBLICATION | $38,298 | $37,756 | $542 | - | 0.0% |
| Fees: accounting | $1,154 | - | $1,154 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $186,032 | $395,065 | reported apart | |||
| Total | $81,626,334 | 100% |
2022 · Form 990 · $82,769,482 spent · pay $28,526,490 · grants $11,407,916 · events $651,263
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other (as described) | MISC PURCHASE SERVICES | $18,988,213 | $15,574,547 | $3,413,666 | - | 22.9% |
| Other salaries and wages | $17,007,292 | $14,669,464 | $2,337,798 | $30 | 20.5% | |
| Grants to US organizations and governments | $11,407,916 | $11,407,916 | - | - | 13.8% | |
| Other (as described) | SUPPLIES | $7,680,454 | $7,630,403 | $50,051 | - | 9.3% |
| Depreciation and depletion | $5,960,714 | $3,535,486 | $2,339,927 | $85,301 | 7.2% | |
| Other employee benefits | $5,454,071 | $4,700,234 | $753,827 | $10 | 6.6% | |
| Fees: management | $3,370,061 | $809,320 | $2,427,960 | $132,781 | 4.1% | |
| Occupancy | $2,834,683 | $1,781,629 | $1,010,069 | $42,985 | 3.4% | |
| Pay: officers, directors, trustees, key employees | $2,386,134 | $2,058,136 | $327,994 | $4 | 2.9% | |
| Payroll taxes | $1,793,554 | $1,547,012 | $246,539 | $3 | 2.2% | |
| Pay: disqualified persons | $1,317,016 | $1,135,979 | $181,035 | $2 | 1.6% | |
| Office expenses | $930,483 | $569,149 | $361,257 | $77 | 1.1% | |
| Other (as described) | EQUIP RENTAL AND MACH | $746,048 | $746,048 | - | - | 0.9% |
| Insurance | $622,193 | $191,029 | $431,164 | - | 0.8% | |
| Pension plan contributions | $568,423 | $490,288 | $78,134 | $1 | 0.7% | |
| Fees: investment management | $518,284 | - | $518,284 | - | 0.6% | |
| Travel | $424,576 | $401,220 | $21,688 | $1,668 | 0.5% | |
| Fees: legal | $305,462 | $9,380 | $296,082 | - | 0.4% | |
| Conferences, conventions and meetings | $250,202 | $237,783 | $12,226 | $193 | 0.3% | |
| Other (as described) | PRINTING AND PUB | $77,300 | $77,229 | $71 | - | 0.1% |
| Fees: professional fundraisers | $68,750 | - | - | $68,750 | 0.1% | |
| All other expenses | $60,212 | $54,928 | $3,652 | $1,632 | 0.1% | |
| Information technology | $44,721 | $31,961 | $12,760 | - | 0.1% | |
| Advertising and promotion | $2,934 | $1,380 | $1,554 | - | 0.0% | |
| Fees: accounting | -$50,214 | - | -$50,214 | - | -0.1% | |
| Fundraising events Event | direct expenses; gross income $116,763 | $401,061 | reported apart | |||
| Total | $82,769,482 | 100% |
2021 · Form 990 · $98,047,633 spent · pay $53,672,246 · grants $15,304,301 · events $619,743
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $40,241,076 | $31,943,319 | $6,633,714 | $1,664,043 | 41.0% | |
| Grants to US organizations and governments | $15,248,807 | $15,248,807 | - | - | 15.6% | |
| Other (as described) | MISC PURCHASE SERVICES | $10,679,759 | $3,531,224 | $6,453,646 | $694,889 | 10.9% |
| Other (as described) | SUPPLIES | $7,933,060 | $7,911,962 | $14,393 | $6,705 | 8.1% |
| Other employee benefits | $7,688,032 | $6,116,030 | $1,270,124 | $301,878 | 7.8% | |
| Depreciation and depletion | $5,510,913 | $3,268,695 | $2,163,354 | $78,864 | 5.6% | |
| Occupancy | $2,629,618 | $1,654,943 | $934,746 | $39,929 | 2.7% | |
| Payroll taxes | $2,231,770 | $1,775,431 | $368,706 | $87,633 | 2.3% | |
| Pay: officers, directors, trustees, key employees | $2,137,624 | $1,770,038 | $367,586 | - | 2.2% | |
| Pension plan contributions | $1,373,744 | $1,092,849 | $226,954 | $53,941 | 1.4% | |
| Other (as described) | EQUIPMENT RENTAL AND MA | $498,095 | $498,095 | - | - | 0.5% |
| Fees: legal | $379,062 | - | $379,062 | - | 0.4% | |
| Insurance | $361,944 | $258,766 | $103,178 | - | 0.4% | |
| Information technology | $342,359 | $49,750 | $284,673 | $7,936 | 0.3% | |
| Travel | $339,600 | $257,523 | $31,241 | $50,836 | 0.3% | |
| Other (as described) | PRINTING AND PUBLICATIO | $282,560 | $74,915 | $879 | $206,766 | 0.3% |
| Conferences, conventions and meetings | $220,959 | $159,544 | $46,634 | $14,781 | 0.2% | |
| All other expenses | $215,023 | $92,397 | $58,092 | $64,534 | 0.2% | |
| Interest | $149,737 | - | $149,737 | - | 0.2% | |
| Fees: accounting | $81,542 | - | $81,542 | - | 0.1% | |
| Fees: investment management | $56,692 | - | $56,692 | - | 0.1% | |
| Grants outside the US | $55,494 | $55,494 | - | - | 0.1% | |
| Fees: professional fundraisers | $27,392 | - | - | $27,392 | 0.0% | |
| Advertising and promotion | $6,174 | $45 | $5,025 | $1,104 | 0.0% | |
| Office expenses | -$643,403 | $981,541 | -$1,659,982 | $35,038 | -0.7% | |
| Fundraising events Event | direct expenses; gross income $729,300 | $398,784 | reported apart | |||
| Total | $98,047,633 | 100% |
2020 · Form 990 · $90,420,592 spent · pay $49,876,233 · grants $10,148,775 · events $371,280
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $38,772,515 | $32,135,129 | $4,946,971 | $1,690,415 | 42.9% | |
| Fees: other services | $12,912,663 | $6,349,164 | $5,976,214 | $587,285 | 14.3% | |
| Grants to US organizations and governments | $10,148,775 | $10,148,775 | - | - | 11.2% | |
| Other (as described) | SUPPLIES | $6,748,221 | $6,555,372 | $190,221 | $2,628 | 7.5% |
| Other employee benefits | $5,433,985 | $4,329,592 | $883,817 | $220,576 | 6.0% | |
| Pay: officers, directors, trustees, key employees | $2,871,597 | $1,045,312 | $1,826,285 | - | 3.2% | |
| Depreciation and depletion | $2,861,895 | $1,698,788 | $1,122,120 | $40,987 | 3.2% | |
| Payroll taxes | $2,716,813 | $2,164,653 | $441,879 | $110,281 | 3.0% | |
| Occupancy | $2,369,057 | $1,500,157 | $832,706 | $36,194 | 2.6% | |
| Office expenses | $1,715,959 | $1,178,710 | $479,275 | $57,974 | 1.9% | |
| Insurance | $556,884 | $194,731 | $362,153 | - | 0.6% | |
| Information technology | $503,815 | $54,260 | $433,493 | $16,062 | 0.6% | |
| Fees: legal | $447,630 | $50 | $447,580 | - | 0.5% | |
| Fees: investment management | $441,545 | - | $441,545 | - | 0.5% | |
| Interest | $433,032 | - | $433,032 | - | 0.5% | |
| Fees: professional fundraisers | $377,465 | - | - | $377,465 | 0.4% | |
| Other (as described) | EQUIP. RENTAL & MAINT. | $329,984 | $329,984 | - | - | 0.4% |
| Conferences, conventions and meetings | $214,493 | $171,096 | $29,884 | $13,513 | 0.2% | |
| Fees: accounting | $211,544 | - | $211,544 | - | 0.2% | |
| Other (as described) | POSTAGE & SHIPPING | $105,013 | $37,618 | $46,893 | $20,502 | 0.1% |
| Other (as described) | PRINTING & PUBLICATIONS | $84,283 | $60,371 | $447 | $23,465 | 0.1% |
| Pension plan contributions | $81,323 | $64,795 | $13,227 | $3,301 | 0.1% | |
| Travel | $51,824 | $13,005 | $5,772 | $33,047 | 0.1% | |
| All other expenses | $24,645 | $24,124 | $521 | - | 0.0% | |
| Advertising and promotion | $5,632 | - | $3,985 | $1,647 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $879,057 | $156,787 | reported apart | |||
| Total | $90,420,592 | 100% |
2019 · Form 990 · $96,451,661 spent · pay $52,142,552 · grants $14,836,872 · events $762,824
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $37,813,506 | $32,038,382 | $4,511,331 | $1,263,793 | 39.2% | |
| Grants to US organizations and governments | $14,836,872 | $14,836,872 | - | - | 15.4% | |
| Fees: other services | $12,651,441 | $6,158,530 | $6,183,648 | $309,263 | 13.1% | |
| Other employee benefits | $6,410,184 | $5,184,987 | $1,028,796 | $196,401 | 6.6% | |
| Other (as described) | SUPPLIES | $6,037,751 | $5,966,449 | $68,263 | $3,039 | 6.3% |
| Pay: officers, directors, trustees, key employees | $3,434,512 | $1,325,784 | $2,108,728 | - | 3.6% | |
| Depreciation and depletion | $2,833,845 | $1,680,842 | $1,112,449 | $40,554 | 2.9% | |
| Payroll taxes | $2,638,295 | $2,134,030 | $423,431 | $80,834 | 2.7% | |
| Occupancy | $2,260,570 | $1,434,778 | $791,175 | $34,617 | 2.3% | |
| Pension plan contributions | $1,846,055 | $1,493,213 | $296,281 | $56,561 | 1.9% | |
| Office expenses | $1,066,782 | $734,452 | $279,135 | $53,195 | 1.1% | |
| Insurance | $1,001,239 | $254,095 | $747,144 | - | 1.0% | |
| Fees: professional fundraisers | $717,633 | - | - | $717,633 | 0.7% | |
| Information technology | $539,801 | $43,716 | $476,461 | $19,624 | 0.6% | |
| Travel | $435,360 | $391,966 | $18,303 | $25,091 | 0.5% | |
| Fees: legal | $424,068 | - | $424,068 | - | 0.4% | |
| Fees: investment management | $382,484 | - | $382,484 | - | 0.4% | |
| Conferences, conventions and meetings | $311,510 | $273,122 | $34,213 | $4,175 | 0.3% | |
| Other (as described) | EQUIP. RENTAL & MAINT. | $192,670 | $192,670 | - | - | 0.2% |
| Other (as described) | POSTAGE & SHIPPING | $191,282 | $98,305 | $54,610 | $38,367 | 0.2% |
| Fees: accounting | $186,480 | $278 | $186,202 | - | 0.2% | |
| Interest | $116,769 | - | $116,769 | - | 0.1% | |
| Other (as described) | PRINTING & PUBLICATIONS | $99,731 | $53,592 | $638 | $45,501 | 0.1% |
| All other expenses | $17,067 | $10,712 | $6,027 | $328 | 0.0% | |
| Advertising and promotion | $5,754 | $8 | $848 | $4,898 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $1,116,771 | $451,314 | reported apart | |||
| Total | $96,451,661 | 100% |
2018 · Form 990 · $94,714,085 spent · pay $55,023,927 · grants $10,418,645 · events $940,098
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $39,974,893 | $34,229,898 | $4,087,712 | $1,657,283 | 42.2% | |
| Grants to US organizations and governments | $10,418,645 | $10,418,645 | - | - | 11.0% | |
| Fees: other services | $10,008,226 | $4,169,599 | $5,508,253 | $330,374 | 10.6% | |
| Other (as described) | SUPPLIES | $7,868,944 | $7,786,092 | $63,848 | $19,004 | 8.3% |
| Other employee benefits | $5,966,533 | $4,911,228 | $833,265 | $222,040 | 6.3% | |
| Pay: officers, directors, trustees, key employees | $4,558,607 | $2,426,931 | $2,131,676 | - | 4.8% | |
| Depreciation and depletion | $2,822,320 | $1,674,006 | $1,107,925 | $40,389 | 3.0% | |
| Payroll taxes | $2,707,356 | $2,228,504 | $378,100 | $100,752 | 2.9% | |
| Occupancy | $2,473,926 | $1,467,363 | $971,160 | $35,403 | 2.6% | |
| Pension plan contributions | $1,816,538 | $1,495,246 | $253,691 | $67,601 | 1.9% | |
| Office expenses | $1,816,508 | $1,212,553 | $510,557 | $93,398 | 1.9% | |
| Travel | $915,182 | $774,964 | $72,906 | $67,312 | 1.0% | |
| Insurance | $662,701 | $296,149 | $366,552 | - | 0.7% | |
| Fees: professional fundraisers | $490,517 | - | - | $490,517 | 0.5% | |
| Information technology | $412,443 | $61,451 | $341,488 | $9,504 | 0.4% | |
| Fees: investment management | $412,415 | - | $412,415 | - | 0.4% | |
| Conferences, conventions and meetings | $353,364 | $309,541 | $31,287 | $12,536 | 0.4% | |
| Fees: legal | $233,772 | - | $233,772 | - | 0.2% | |
| Other (as described) | POSTAGE & SHIPPING | $217,036 | $53,083 | $82,434 | $81,519 | 0.2% |
| Other (as described) | EQUIP. RENTAL & MAINT. | $213,862 | $213,862 | - | - | 0.2% |
| Fees: accounting | $196,730 | - | $196,730 | - | 0.2% | |
| Other (as described) | PRINTING & PUBLICATIONS | $140,618 | $100,555 | $3,243 | $36,820 | 0.1% |
| Interest | $29,596 | - | $29,596 | - | 0.0% | |
| Advertising and promotion | $3,353 | $219 | $672 | $2,462 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $1,224,752 | $586,734 | reported apart | |||
| Total | $94,714,085 | 100% |
2017 · Form 990 · $91,783,272 spent · pay $54,897,616 · grants $9,867,612 · events $894,433
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $43,263,619 | $36,083,242 | $5,371,567 | $1,808,810 | 47.1% | |
| Grants to US organizations and governments | $9,867,612 | $9,867,612 | - | - | 10.8% | |
| Fees: other services | $8,238,853 | $5,315,401 | $2,600,362 | $323,090 | 9.0% | |
| Other employee benefits | $5,921,082 | $4,862,096 | $819,754 | $239,232 | 6.5% | |
| Other (as described) | SUPPLIES | $5,353,949 | $5,291,573 | $44,550 | $17,826 | 5.8% |
| Depreciation and depletion | $2,853,079 | $1,681,472 | $1,130,778 | $40,829 | 3.1% | |
| Information technology | $2,648,496 | $20,288 | $2,612,592 | $15,616 | 2.9% | |
| Occupancy | $2,619,643 | $1,543,896 | $1,038,259 | $37,488 | 2.9% | |
| Payroll taxes | $2,575,230 | $2,114,650 | $356,532 | $104,048 | 2.8% | |
| Pension plan contributions | $1,632,593 | $1,340,604 | $226,027 | $65,962 | 1.8% | |
| Pay: officers, directors, trustees, key employees | $1,505,092 | $678,581 | $826,511 | - | 1.6% | |
| Office expenses | $1,361,104 | $843,723 | $475,159 | $42,222 | 1.5% | |
| Travel | $863,410 | $693,226 | $79,091 | $91,093 | 0.9% | |
| Insurance | $788,281 | $380,607 | $407,674 | - | 0.9% | |
| Fees: professional fundraisers | $413,305 | - | - | $413,305 | 0.5% | |
| Fees: investment management | $412,415 | - | $412,415 | - | 0.4% | |
| Conferences, conventions and meetings | $330,766 | $270,470 | $47,159 | $13,137 | 0.4% | |
| Fees: legal | $274,222 | - | $274,222 | - | 0.3% | |
| Fees: accounting | $214,642 | - | $214,642 | - | 0.2% | |
| Other (as described) | EQUIP. RENTAL & MAINT. | $214,064 | $214,064 | - | - | 0.2% |
| Other (as described) | POSTAGE & SHIPPING | $188,708 | $63,245 | $70,878 | $54,585 | 0.2% |
| Other (as described) | PRINTING & PUBLICATIONS | $166,192 | $66,542 | $6,411 | $93,239 | 0.2% |
| All other expenses | $49,278 | $45,969 | $2,848 | $461 | 0.1% | |
| Advertising and promotion | $25,603 | $7,673 | $17,620 | $310 | 0.0% | |
| Interest | $2,034 | - | $2,034 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $1,620,503 | $563,667 | reported apart | |||
| Total | $91,783,272 | 100% |
2016 · Form 990 · $88,501,958 spent · pay $47,399,856 · grants $8,170,140 · events $755,387
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $38,332,997 | $32,397,570 | $4,365,811 | $1,569,616 | 43.3% | |
| Grants to US organizations and governments | $8,170,140 | $8,170,140 | - | - | 9.2% | |
| Fees: other services | $7,937,529 | $4,285,455 | $3,635,688 | $16,386 | 9.0% | |
| Other (as described) | supplies | $7,617,504 | $7,419,976 | $161,261 | $36,267 | 8.6% |
| Office expenses | $4,586,327 | $2,514,510 | $1,630,823 | $440,994 | 5.2% | |
| Depreciation and depletion | $3,412,554 | $2,011,201 | $1,352,518 | $48,835 | 3.9% | |
| Other employee benefits | $3,264,413 | $2,692,570 | $444,071 | $127,772 | 3.7% | |
| Occupancy | $2,783,423 | $1,356,519 | $1,393,966 | $32,938 | 3.1% | |
| Payroll taxes | $2,459,268 | $2,028,466 | $334,544 | $96,258 | 2.8% | |
| Other (as described) | consulting services | $1,795,040 | $1,795,040 | - | - | 2.0% |
| Pay: officers, directors, trustees, key employees | $1,768,791 | $679,395 | $1,089,396 | - | 2.0% | |
| Pension plan contributions | $1,574,387 | $1,298,594 | $214,170 | $61,623 | 1.8% | |
| Travel | $890,867 | $859,763 | $31,081 | $23 | 1.0% | |
| Insurance | $761,357 | $397,373 | $363,984 | - | 0.9% | |
| All other expenses | $625,444 | $475,113 | $83,741 | $66,590 | 0.7% | |
| Other (as described) | equip. rental & maint. | $508,055 | $508,055 | - | - | 0.6% |
| Fees: investment management | $387,765 | - | $387,765 | - | 0.4% | |
| Fees: professional fundraisers | $371,680 | - | - | $371,680 | 0.4% | |
| Other (as described) | research subcontracts | $367,739 | $367,739 | - | - | 0.4% |
| Fees: legal | $296,347 | - | $296,347 | - | 0.3% | |
| Conferences, conventions and meetings | $290,342 | $225,457 | $60,759 | $4,126 | 0.3% | |
| Fees: accounting | $162,400 | - | $162,400 | - | 0.2% | |
| Advertising and promotion | $86,711 | $7,777 | $78,934 | - | 0.1% | |
| Information technology | $37,695 | $11,247 | $23,564 | $2,884 | 0.0% | |
| Interest | $13,183 | - | $13,183 | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $1,111,999 | $465,045 | reported apart | |||
| Total | $88,501,958 | 100% |
2015 · Form 990 · $93,080,038 spent · pay $47,609,167 · grants $8,087,376 · events $962,481
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $33,909,469 | $27,892,878 | $4,692,384 | $1,324,207 | 36.4% | |
| Other (as described) | RESEARCH SUBCONTRACTS | $8,296,619 | $8,296,619 | - | - | 8.9% |
| Grants to US organizations and governments | $8,087,376 | $8,087,376 | - | - | 8.7% | |
| Other (as described) | SUPPLIES | $5,652,190 | $5,502,096 | $135,759 | $14,335 | 6.1% |
| Fees: other services | $5,233,441 | $1,821,683 | $3,304,000 | $107,758 | 5.6% | |
| Pay: officers, directors, trustees, key employees | $5,138,337 | $3,217,727 | $1,920,610 | - | 5.5% | |
| Other (as described) | CONSULTING SERVICES | $4,520,502 | $4,520,502 | - | - | 4.9% |
| Depreciation and depletion | $4,506,840 | $2,656,122 | $1,786,223 | $64,495 | 4.8% | |
| Other employee benefits | $4,433,401 | $3,532,228 | $750,825 | $150,348 | 4.8% | |
| Payroll taxes | $2,529,075 | $2,014,993 | $428,315 | $85,767 | 2.7% | |
| Occupancy | $2,506,109 | $1,476,984 | $993,261 | $35,864 | 2.7% | |
| Office expenses | $2,471,918 | $1,413,920 | $981,699 | $76,299 | 2.7% | |
| Pension plan contributions | $1,598,885 | $1,273,882 | $270,781 | $54,222 | 1.7% | |
| All other expenses | $702,646 | $264,540 | $151,309 | $286,797 | 0.8% | |
| Insurance | $688,011 | $381,158 | $306,853 | - | 0.7% | |
| Travel | $582,402 | $528,995 | $46,002 | $7,405 | 0.6% | |
| Fees: investment management | $348,213 | - | $348,213 | - | 0.4% | |
| Other (as described) | EQUIP. RENTAL & MAINT. | $347,436 | $347,436 | - | - | 0.4% |
| Conferences, conventions and meetings | $325,715 | $218,522 | $63,064 | $44,129 | 0.3% | |
| Fees: legal | $310,568 | $225 | $310,343 | - | 0.3% | |
| Fees: professional fundraisers | $245,945 | - | - | $245,945 | 0.3% | |
| Fees: accounting | $216,422 | $67,456 | $148,966 | - | 0.2% | |
| Information technology | $192,247 | $139,865 | $47,009 | $5,373 | 0.2% | |
| Advertising and promotion | $159,247 | $80,485 | $70,430 | $8,332 | 0.2% | |
| Interest | $77,024 | - | $77,024 | - | 0.1% | |
| Fundraising events Event | direct expenses; gross income $1,053,862 | $636,766 | reported apart | |||
| Total | $93,080,038 | 100% |
2014 · Form 990 · $95,799,796 spent · pay $49,748,759 · grants $8,981,501 · events $883,071
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $35,353,710 | $27,887,699 | $5,927,129 | $1,538,882 | 36.9% | |
| Other (as described) | RESEARCH SUBCONTRACTS | $10,465,982 | $10,465,982 | - | - | 10.9% |
| Grants to US organizations and governments | $8,981,501 | $8,981,501 | - | - | 9.4% | |
| Fees: other services | $6,292,411 | $3,652,465 | $2,600,313 | $39,633 | 6.6% | |
| Other (as described) | SUPPLIES | $5,145,425 | $5,031,971 | $100,090 | $13,364 | 5.4% |
| Other employee benefits | $5,013,602 | $3,888,262 | $934,058 | $191,282 | 5.2% | |
| Pay: officers, directors, trustees, key employees | $4,981,203 | $3,393,748 | $1,587,455 | - | 5.2% | |
| Depreciation and depletion | $4,231,465 | $2,493,829 | $1,677,082 | $60,554 | 4.4% | |
| Office expenses | $3,206,628 | $1,834,187 | $1,324,230 | $48,211 | 3.3% | |
| Payroll taxes | $2,595,745 | $2,013,111 | $483,600 | $99,034 | 2.7% | |
| Occupancy | $2,499,099 | $1,472,853 | $990,483 | $35,763 | 2.6% | |
| Pension plan contributions | $1,804,499 | $1,399,466 | $336,187 | $68,846 | 1.9% | |
| Insurance | $702,946 | $420,390 | $282,556 | - | 0.7% | |
| Fees: legal | $696,465 | $525,148 | $171,317 | - | 0.7% | |
| Travel | $647,705 | $550,239 | $84,342 | $13,124 | 0.7% | |
| Conferences, conventions and meetings | $411,028 | $276,099 | $87,193 | $47,736 | 0.4% | |
| Other (as described) | PRINTING & PUBLICATIONS | $404,861 | $161,020 | $2,871 | $240,970 | 0.4% |
| Fees: investment management | $403,609 | - | $403,609 | - | 0.4% | |
| Fees: professional fundraisers | $399,986 | - | - | $399,986 | 0.4% | |
| All other expenses | $385,315 | $275,272 | $110,043 | - | 0.4% | |
| Other (as described) | POSTAGE & SHIPPING | $337,974 | $128,207 | $113,113 | $96,654 | 0.4% |
| Advertising and promotion | $288,761 | $51,585 | $228,971 | $8,205 | 0.3% | |
| Information technology | $280,376 | $208,618 | $65,006 | $6,752 | 0.3% | |
| Fees: accounting | $166,380 | $54,906 | $111,474 | - | 0.2% | |
| Interest | $103,120 | - | $103,120 | - | 0.1% | |
| Fundraising events Event | direct expenses; gross income $1,041,779 | $472,043 | reported apart | |||
| Total | $95,799,796 | 100% |
2013 · Form 990 · $95,699,704 spent · pay $50,893,356 · grants $6,978,115 · events $1,006,853
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $38,189,982 | $31,167,231 | $5,668,442 | $1,354,309 | 39.9% | |
| Fees: other services | $9,205,687 | $5,804,015 | $3,238,069 | $163,603 | 9.6% | |
| Other (as described) | RESEARCH SUBCONTRACTS | $7,653,797 | $7,653,797 | - | - | 8.0% |
| Grants to US organizations and governments | $6,978,115 | $6,978,115 | - | - | 7.3% | |
| Other (as described) | SUPPLIES | $5,617,444 | $5,478,165 | $127,941 | $11,338 | 5.9% |
| Other employee benefits | $4,681,654 | $3,714,660 | $814,721 | $152,273 | 4.9% | |
| Depreciation and depletion | $4,484,427 | $2,652,701 | $1,767,314 | $64,412 | 4.7% | |
| Pay: officers, directors, trustees, key employees | $3,448,373 | $1,870,732 | $1,577,641 | - | 3.6% | |
| Payroll taxes | $2,678,861 | $2,125,543 | $466,187 | $87,131 | 2.8% | |
| Occupancy | $2,535,915 | $1,500,086 | $999,405 | $36,424 | 2.6% | |
| Office expenses | $2,500,598 | $1,089,531 | $1,321,387 | $89,680 | 2.6% | |
| Pension plan contributions | $1,894,486 | $1,503,180 | $329,687 | $61,619 | 2.0% | |
| Travel | $1,159,941 | $980,799 | $147,719 | $31,423 | 1.2% | |
| Other (as described) | TELEPHONE | $844,105 | $592,778 | $109,463 | $141,864 | 0.9% |
| Insurance | $658,731 | $474,412 | $184,319 | - | 0.7% | |
| Fees: legal | $637,031 | $2,535 | $634,429 | $67 | 0.7% | |
| Information technology | $488,302 | $274,413 | $208,573 | $5,316 | 0.5% | |
| Fees: investment management | $470,892 | - | $470,892 | - | 0.5% | |
| Conferences, conventions and meetings | $369,238 | $252,002 | $82,778 | $34,458 | 0.4% | |
| Fees: professional fundraisers | $358,777 | - | - | $358,777 | 0.4% | |
| Advertising and promotion | $303,090 | $118,364 | $184,726 | - | 0.3% | |
| Other (as described) | EQUIP. RENTAL/MAINT. | $247,115 | $247,115 | - | - | 0.3% |
| Interest | $152,943 | - | $152,943 | - | 0.2% | |
| Fees: accounting | $140,200 | $47,422 | $92,778 | - | 0.1% | |
| Fundraising events Event | direct expenses; gross income $1,090,222 | $637,615 | reported apart | |||
| Total | $95,699,704 | 100% |
2012 · Form 990 · $92,662,914 spent · pay $51,037,694 · grants $6,235,072 · events $1,094,102
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $38,602,575 | $31,909,757 | $5,180,169 | $1,512,649 | 41.7% | |
| Fees: other services | $8,177,012 | $5,214,518 | $2,951,098 | $11,396 | 8.8% | |
| Grants to US organizations and governments | $6,235,072 | $6,235,072 | - | - | 6.7% | |
| Other (as described) | SUPPLIES | $5,958,689 | $5,772,360 | $172,205 | $14,124 | 6.4% |
| Other (as described) | RESEARCH CONSULTING | $5,532,924 | $5,532,924 | - | - | 6.0% |
| Other employee benefits | $4,921,341 | $3,925,619 | $816,924 | $178,798 | 5.3% | |
| Depreciation and depletion | $4,114,661 | $2,433,971 | $1,621,589 | $59,101 | 4.4% | |
| Pay: officers, directors, trustees, key employees | $3,032,423 | $1,301,339 | $1,731,084 | - | 3.3% | |
| Payroll taxes | $2,669,436 | $2,129,336 | $443,116 | $96,984 | 2.9% | |
| Occupancy | $2,385,494 | $1,411,106 | $940,124 | $34,264 | 2.6% | |
| All other expenses | $2,314,251 | $1,898,370 | $337,312 | $78,569 | 2.5% | |
| Pension plan contributions | $1,811,919 | $1,445,318 | $300,772 | $65,829 | 2.0% | |
| Other (as described) | EQUIP. RENTAL/MAINT. | $1,520,212 | $505,846 | $950,862 | $63,504 | 1.6% |
| Travel | $894,339 | $795,892 | $74,316 | $24,131 | 1.0% | |
| Fees: legal | $865,289 | $138,199 | $727,090 | - | 0.9% | |
| Insurance | $691,755 | $427,512 | $264,243 | - | 0.7% | |
| Other (as described) | PRINTING & PUBLICATIONS | $682,135 | $548,359 | $6,390 | $127,386 | 0.7% |
| Conferences, conventions and meetings | $460,604 | $339,978 | $110,100 | $10,526 | 0.5% | |
| Fees: investment management | $459,575 | - | $459,575 | - | 0.5% | |
| Fees: professional fundraisers | $372,938 | - | - | $372,938 | 0.4% | |
| Information technology | $354,366 | $209,623 | $138,384 | $6,359 | 0.4% | |
| Advertising and promotion | $237,544 | $164,752 | $71,252 | $1,540 | 0.3% | |
| Interest | $195,060 | - | $195,060 | - | 0.2% | |
| Fees: accounting | $173,300 | $61,947 | $111,353 | - | 0.2% | |
| Fundraising events Event | direct expenses; gross income - | $633,498 | reported apart | |||
| Total | $92,662,914 | 100% |
2011 · Form 990 · $89,954,142 spent · pay $49,826,411 · grants $5,398,708 · events $1,152,035
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $38,286,858 | $30,942,592 | $5,981,511 | $1,362,755 | 42.6% | |
| Fees: other services | $12,505,505 | $10,148,623 | $2,344,500 | $12,382 | 13.9% | |
| Other (as described) | SUPPLIES | $7,379,986 | $7,218,086 | $148,283 | $13,617 | 8.2% |
| Grants to US organizations and governments | $5,398,708 | $5,398,708 | - | - | 6.0% | |
| Other employee benefits | $5,111,018 | $4,071,451 | $867,558 | $172,009 | 5.7% | |
| Depreciation and depletion | $3,618,173 | $2,023,319 | $1,545,725 | $49,129 | 4.0% | |
| Payroll taxes | $2,602,185 | $2,072,908 | $441,702 | $87,575 | 2.9% | |
| Pay: officers, directors, trustees, key employees | $2,205,579 | $1,313,797 | $891,782 | - | 2.5% | |
| Occupancy | $1,922,902 | $1,382,709 | $506,619 | $33,574 | 2.1% | |
| Other (as described) | EQUIP. RENTAL/MAINT. | $1,846,742 | $493,096 | $1,331,480 | $22,166 | 2.1% |
| Pension plan contributions | $1,620,771 | $1,291,111 | $275,114 | $54,546 | 1.8% | |
| All other expenses | $1,305,909 | $1,046,891 | $250,114 | $8,904 | 1.5% | |
| Fees: legal | $1,140,697 | $16,559 | $1,124,138 | - | 1.3% | |
| Travel | $997,003 | $875,310 | $99,136 | $22,557 | 1.1% | |
| Other (as described) | PRINTING & PUBLICATIONS | $739,352 | $631,231 | $7,939 | $100,182 | 0.8% |
| Insurance | $704,044 | $419,006 | $285,038 | - | 0.8% | |
| Fees: professional fundraisers | $408,988 | - | - | $408,988 | 0.5% | |
| Other (as described) | POSTAGE & SHIPPING | $408,910 | $240,482 | $117,617 | $50,811 | 0.5% |
| Fees: investment management | $405,508 | - | $405,508 | - | 0.5% | |
| Conferences, conventions and meetings | $383,294 | $255,788 | $107,397 | $20,109 | 0.4% | |
| Information technology | $346,367 | $216,471 | $81,643 | $48,253 | 0.4% | |
| Advertising and promotion | $235,016 | $70,456 | $152,792 | $11,768 | 0.3% | |
| Interest | $233,143 | - | $233,143 | - | 0.3% | |
| Fees: accounting | $147,484 | $36,876 | $110,608 | - | 0.2% | |
| Fundraising events Event | direct expenses; gross income - | $768,741 | reported apart | |||
| Total | $89,954,142 | 100% |
2010 · Form 990 · $85,455,938 spent · pay $46,819,852 · grants $4,795,503 · events $1,095,085
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $32,420,066 | $28,395,610 | $3,242,410 | $782,046 | 37.9% | |
| Fees: other services | $10,567,721 | $8,782,077 | $1,664,573 | $121,071 | 12.4% | |
| Other (as described) | SUPPLIES | $7,676,746 | $7,427,551 | $222,274 | $26,921 | 9.0% |
| Other employee benefits | $5,402,854 | $4,485,030 | $716,216 | $201,608 | 6.3% | |
| Pay: officers, directors, trustees, key employees | $5,077,263 | $2,733,838 | $1,726,709 | $616,716 | 5.9% | |
| Grants to US organizations and governments | $4,795,503 | $4,795,503 | - | - | 5.6% | |
| Depreciation and depletion | $3,057,765 | $1,808,779 | $1,205,066 | $43,920 | 3.6% | |
| Occupancy | $2,605,290 | $1,541,123 | $1,026,746 | $37,421 | 3.0% | |
| Payroll taxes | $2,358,026 | $1,957,760 | $312,344 | $87,922 | 2.8% | |
| Other (as described) | EQUIP. RENTAL/MAINT. | $1,820,517 | $657,681 | $1,148,091 | $14,745 | 2.1% |
| Pension plan contributions | $1,561,643 | $1,296,560 | $206,855 | $58,228 | 1.8% | |
| All other expenses | $1,509,857 | $1,069,909 | $368,882 | $71,066 | 1.8% | |
| Fees: legal | $1,244,741 | $1,871 | $1,242,150 | $720 | 1.5% | |
| Other (as described) | PATIENT SUBJECT COSTS | $1,145,122 | $1,145,122 | - | - | 1.3% |
| Travel | $1,002,594 | $874,031 | $49,639 | $78,924 | 1.2% | |
| Insurance | $711,546 | $434,617 | $276,929 | - | 0.8% | |
| Other (as described) | PRINTING & PUBLICATIONS | $506,673 | $426,156 | $38 | $80,479 | 0.6% |
| Other (as described) | PERM. RESEARCH EQUIP. | $409,825 | $409,825 | - | - | 0.5% |
| Fees: investment management | $388,972 | - | $388,972 | - | 0.5% | |
| Advertising and promotion | $320,897 | $168,004 | $152,893 | - | 0.4% | |
| Information technology | $277,134 | $123,979 | $140,215 | $12,940 | 0.3% | |
| Conferences, conventions and meetings | $248,781 | $172,734 | $65,955 | $10,092 | 0.3% | |
| Fees: accounting | $192,780 | $39,600 | $153,180 | - | 0.2% | |
| Interest | $153,622 | - | $153,622 | - | 0.2% | |
| Fundraising events Event | direct expenses; gross income - | $846,304 | reported apart | |||
| Total | $85,455,938 | 100% |
2009 · Form 990 · $96,356,934 spent · pay $48,921,883 · grants $0 · events $1,257,955
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $35,969,153 | $29,017,096 | $5,147,166 | $1,804,891 | 37.3% | |
| Fees: other services | $13,458,881 | $9,570,927 | $3,348,310 | $539,644 | 14.0% | |
| Other (as described) | supplies | $6,972,246 | $6,574,807 | $284,323 | $113,116 | 7.2% |
| Other employee benefits | $5,418,136 | $4,650,095 | $507,301 | $260,740 | 5.6% | |
| Other (as described) | deficit contribution | $5,169,722 | $5,169,722 | - | - | 5.4% |
| All other expenses | $3,488,204 | $2,622,254 | $427,128 | $438,822 | 3.6% | |
| Pay: officers, directors, trustees, key employees | $3,403,351 | $1,608,891 | $1,794,460 | - | 3.5% | |
| Depreciation and depletion | $3,185,514 | $1,884,347 | $1,255,412 | $45,755 | 3.3% | |
| Other (as described) | equip. rental/maint. | $2,541,421 | $979,348 | $1,488,588 | $73,485 | 2.6% |
| Payroll taxes | $2,479,444 | $1,928,641 | $437,142 | $113,661 | 2.6% | |
| Other (as described) | perm. research equip. | $2,412,575 | $2,412,575 | - | - | 2.5% |
| Occupancy | $2,391,517 | $1,494,571 | $860,655 | $36,291 | 2.5% | |
| Other (as described) | amounts held as agent | $1,842,684 | $1,842,684 | - | - | 1.9% |
| Pension plan contributions | $1,651,799 | $1,284,855 | $291,223 | $75,721 | 1.7% | |
| Travel | $1,547,966 | $844,451 | $66,802 | $636,713 | 1.6% | |
| Insurance | $1,223,475 | $723,730 | $482,172 | $17,573 | 1.3% | |
| Fees: legal | $1,154,674 | $420,093 | $734,529 | $52 | 1.2% | |
| Conferences, conventions and meetings | $438,789 | $281,215 | $61,516 | $96,058 | 0.5% | |
| Fees: accounting | $363,202 | $70,288 | $292,914 | - | 0.4% | |
| Information technology | $342,382 | $180,732 | $146,129 | $15,521 | 0.4% | |
| Fees: professional fundraisers | $296,085 | - | - | $296,085 | 0.3% | |
| Advertising and promotion | $264,066 | $90,534 | $173,532 | - | 0.3% | |
| Interest | $207,559 | $122,779 | $81,799 | $2,981 | 0.2% | |
| Fees: investment management | $134,089 | - | - | $134,089 | 0.1% | |
| Fundraising events Event | direct expenses; gross income - | $819,166 | reported apart | |||
| Total | $96,356,934 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2006 | $40,000 | 2 | |
| 2005 | $40,000 | 2 | |
| 2004 | $40,000 | 2 | |
| 2003 | $40,000 | 2 | |
| 2002 | $40,000 | 2 | |
| 2001 | $40,000 | 2 | |
| 2000 | $40,000 | 2 | |
| 1999 | $40,000 | 2 |
Issues: Medical/Disease Research/Clinical Labs
Firms hired: BEVELS CONSULTING, TERRY, WASHINGTON TECHNOLOGY STRATEGIES
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2027 | $0 | $0 | 1 |
| 2026 | $19,084,678 | $0 | 42 |
| 2025 | $22,227,871 | $0 | 44 |
| 2024 | $24,603,092 | $0 | 50 |
| 2023 | $21,061,254 | $0 | 43 |
| 2022 | $21,025,413 | $0 | 47 |
| 2021 | $17,157,724 | $0 | 43 |
| 2020 | $15,014,625 | $12,515 | 43 |
| 2019 | $13,203,303 | $0 | 36 |
| 2018 | $14,614,594 | $0 | 44 |
| 2017 | $24,947,190 | $0 | 43 |
| 2016 | $23,085,705 | $237,200 | 37 |
| 2015 | $12,483,350 | $972,175 | 33 |
| 2014 | $14,783,543 | $35,567 | 35 |
| 2013 | $39,515,166 | $415,604 | 36 |
| 2012 | $19,064,689 | $1,152,111 | 45 |
| 2011 | $20,102,638 | $911,278 | 41 |
| 2010 | $20,268,280 | $3,775,164 | 46 |
| 2009 | $20,985,539 | $2,029,781 | 49 |
| 2008 | $12,980,637 | $2,047,391 | 32 |
| 2007 | $16,820,662 | $2,724,682 | 34 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EPITRANSCRIPTOMICS IN HUMAN OBESITY AND TYPE 2 DIABETES - PROJECT SUMMARY DYSFUNCTION OF MULTIPLE METABOLIC CELLS CONTRIBUTE TO THE PATHOPHYSIOLOGY OF THE TWO M | $1,968,589 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIABETES AND ENDOCRINOLOGY RESEARCH CENTER | $1,706,072 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INVESTIGATING THE MECHANISTIC ROLE OF BROWN FAT-DERIVED LIPID MEDIATORS AND THEIR ANALOGS IN METABOLIC HEALTH - PROJECT SUMMARY/ABSTRACT OBESITY CONTRIBUTES TO | $868,285 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INSULIN RECEPTOR STRUCTURE AND TURNOVER | $866,374 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF RISK FACTORS FOR EXCESSIVE CARDIOVASCULAR DISEASES (CVD) FROM CIRCULATING AND CARDIOVASCULAR TISSUES OF PEOPLE WITH WELL-CONTROLLED CHRONIC | $849,124 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EARLY MYOCARDIAL REMODELING AND PROGRESSIVE KIDNEY FUNCTION DECLINE IN TYPE 1 DIABETES - SUMMARY A LARGE PROPORTION OF THE EXCESS CVD MORBIDITY AND MORTALITY EX | $828,756 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TARGETING RENALASE FOR EARLY STAGE T1D TREATMENT - PROJECT SUMMARY/ABSTRACT TYPE 1 DIABETES (T1D) IS AN AUTOIMMUNE DISEASE THAT DESTROYS INSULIN-PRODUCING BETA | $826,321 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL MECHANISMS FOR EXERCISE TRAINING EFFECTS ON GLUCOSE HOMEOSTASIS | $716,991 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLUCAGON PUMP THERAPY FOR POST-BARIATRIC HYPOGLYCEMIA: MERGING PHYSIOLOGY AND ENGINEERING - PROJECT SUMMARY/ABSTRACT BARIATRIC SURGERY IS A POTENT TREATMENT FO | $709,250 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF IGF-1 AND INSULIN RECEPTORS BETA-CELL SURVIVAL | $703,778 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENTAL GENES AND THE ORIGIN OF FAT | $701,100 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSLATIONAL PROGRAMMING OF BETA-CELLS IN RESPONSE TO GLUCOSE TOXICITY - ABSTRACT CONTROL OF INSULIN BIOSYNTHESIS IN BETA-CELLS OCCURS PRIMARILY AT THE LEVEL O | $694,309 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXERCISE REGULATION OF GLUCOSE HOMEOSTASIS ADMINISTRATIVE SUPPLEMENT | $687,200 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING, PREDICTING AND PREVENTING TYPE 2 DIABETES IN YOUTH, BOSTON CLINICAL CENTER (UPP STUDY) - PROJECT SUMMARY / ABSTRACT RISING OBESITY HAS LED TO AN | $663,241 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IDENTIFYING TARGETS FOR PREVENTING NEUROCOGNITIVE COMPLICATIONS IN YOUTH WITH T1D - PROJECT SUMMARY/ABSTRACT EARLY CHILDHOOD IS A CRITICAL TIME IN BRAIN DEVELOP | $631,247 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL EXERCISE DURING LACTATION TO IGNITE INFANT METABOLISM - PROJECT SUMMARY/ABSTRACT BREASTFEEDING REDUCES RISK OF CHILDHOOD OBESITY AND DIABETES, BUT THE | $631,027 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | EVALUATING CLINICAL AND PATHOLOGICAL MARKERS OF COGNITIVE DECLINE AND ALZHEIMER'S DEMENTIA IN LONG-DURATION TYPE 1 DIABETES. - ABSTRACT THE BURDEN OF DIABETES-A | $629,622 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF THERMOGENIC ADIPOCYTE PROGRAM - PROJECT SUMMARY/ABSTRACT OBESITY AND ITS METABOLIC SEQUELAE ARE RAPIDLY INCREASING | $602,295 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | LIPOTOXICITY AND MAINTENANCE OF METABOLIC HEALTH - ABSTRACT LIPOTOXICITY IS AN IMPORTANT MECHANISM OF COMPLICATIONS IN TYPE 2 DIABETES, INCLUDING NON-ALCOHOLIC | $597,775 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GUT MICROBIAL FERMENTATION PRODUCTS OF MUSCLE-DERIVED LACTATE AS MEDIATORS OF EXERCISE AND METABOLISM - PROJECT SUMMARY/ABSTRACT THE GUT MICROBIOME MAKES SIGNIF | $568,630 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MODULATING THE ADAPTIVE IMMUNE RESPONSE TO ENHANCE THE EFFICIENCY OF IN VIVO GENE EDITING IN MUSCLE - PROJECT SUMMARY DUCHENNE MUSCULAR DYSTROPHY (DMD) IS A DEB | $545,534 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNCOVERING CONSERVED LIPID HOMEOSTASIS MECHANISMS THAT MEDIATE LONGEVITY AFTER GERM CELL LOSS IN C. ELEGANS | $525,247 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ELUCIDATING AND TARGETING BETA-CELL SENESCENCE AND ITS SASP - ABSTRACT THIS PROPOSAL SEEKS TO ELUCIDATE THE MECHANISMS OF SS-CELL SENESCENCE, AN AGING HALLMARK, | $427,500 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | JOSLIN-BIDMC POSTBAC PROGRAM IN DIABETES AND METABOLISM - ABSTRACT THE UNITED STATES STRUGGLES TO CULTIVATE A BIOMEDICAL RESEARCH WORKFORCE THAT REFLECTS THE DI | $397,444 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | KIDNEY TRANSPLANT OUTCOMES AND APOL1 | $217,381 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PRECISION MONITORING: UNDERSTANDING MOMENTARY AFFECT, GLUCOSE, AND SELF-CARE BEHAVIORS IN ADOLESCENTS AND YOUNG ADULTS WITH TYPE 1 DIABETES - PROJECT SUMMARY/AB | $190,209 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF AN INTERVENTION TO TARGET DIABETES DEVICE USE THROUGH AN IDENTITY FRAMEWORK: ACCPTECH (ADAPT AND COMMIT TO CGM AND PUMP TECHNOLOGY) - PROJECT SUM | $188,784 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DRIVERS OF HUMAN INSULIN RESISTANCE AND SEX-SPECIFIC ALTERATIONS - PROJECT SUMMARY/ABSTRACT INSULIN RESISTANCE IS A MAJOR RISK FACTOR IN THE DEVELOPMENT OF TYPE | $149,083 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRAINING GRANT IN DIABETES AND METABOLISM | $1 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING THE ROLE OF THE COMPLEMENT PROTEOME IN PROGRESSIVE DIABETIC KIDNEY DISEASE | -$6,490 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EPITRANSCRIPTOMICS IN HUMAN OBESITY AND TYPE 2 DIABETES - PROJECT SUMMARY DYSFUNCTION OF MULTIPLE METABOLIC CELLS CONTRIBUTE TO THE PATHOPHYSIOLOGY OF THE TWO M | $1,972,780 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIABETES AND ENDOCRINOLOGY RESEARCH CENTER | $1,706,072 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF RISK FACTORS FOR EXCESSIVE CARDIOVASCULAR DISEASES (CVD) FROM CIRCULATING AND CARDIOVASCULAR TISSUES OF PEOPLE WITH WELL-CONTROLLED CHRONIC | $1,020,124 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING, PREDICTING AND PREVENTING TYPE 2 DIABETES IN YOUTH, BOSTON CLINICAL CENTER (UPP STUDY) - PROJECT SUMMARY / ABSTRACT RISING OBESITY HAS LED TO AN | $994,789 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | USING EX VIVO, IN VIVO MODELS AND PATIENT MUTATIONS TO INTERROGATE PANCREATIC EXOCRINE-ENDOCRINE CROSS TALK - PROJECT SUMMARY TYPE 1 DIABETES AND ITS METABOLIC | $882,433 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRAINING GRANT IN DIABETES AND METABOLISM | $828,792 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EARLY MYOCARDIAL REMODELING AND PROGRESSIVE KIDNEY FUNCTION DECLINE IN TYPE 1 DIABETES - SUMMARY A LARGE PROPORTION OF THE EXCESS CVD MORBIDITY AND MORTALITY EX | $811,054 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF CARDIOVASCULAR DISEASES (CVD) IN PEOPLE WITH LONG DURATION TYPE 1 DIABETES - ABSTRACT CARDIOVASCULAR DISEASE (CVD) IS THE MAJOR CAUSE OF MOR | $758,888 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL MECHANISMS FOR EXERCISE TRAINING EFFECTS ON GLUCOSE HOMEOSTASIS | $730,615 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLUCAGON PUMP THERAPY FOR POST-BARIATRIC HYPOGLYCEMIA: MERGING PHYSIOLOGY AND ENGINEERING - PROJECT SUMMARY/ABSTRACT BARIATRIC SURGERY IS A POTENT TREATMENT FO | $715,307 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF IGF-1 AND INSULIN RECEPTORS BETA-CELL SURVIVAL | $711,982 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSLATIONAL PROGRAMMING OF BETA-CELLS IN RESPONSE TO GLUCOSE TOXICITY - ABSTRACT CONTROL OF INSULIN BIOSYNTHESIS IN BETA-CELLS OCCURS PRIMARILY AT THE LEVEL O | $707,452 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DISSECTING THE THERMOGENIC ADIPOSE NICHE - PROJECT SUMMARY/ABSTRACT ADIPOSE TISSUE PLAYS A CRITICAL ROLE IN THE REGULATION OF WHOLE-BODY ENERGY METABOLISM, AND | $701,614 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENTAL GENES AND THE ORIGIN OF FAT | $701,100 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXERCISE REGULATION OF GLUCOSE HOMEOSTASIS ADMINISTRATIVE SUPPLEMENT | $700,041 |
| 2025 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MATERNAL EXERCISE DURING LACTATION TO IGNITE INFANT METABOLISM - PROJECT SUMMARY/ABSTRACT BREASTFEEDING REDUCES RISK OF CHILDHOOD OBESITY AND DIABETES, BUT THE | $657,909 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | EVALUATING CLINICAL AND PATHOLOGICAL MARKERS OF COGNITIVE DECLINE AND ALZHEIMER'S DEMENTIA IN LONG-DURATION TYPE 1 DIABETES. - ABSTRACT THE BURDEN OF DIABETES-A | $645,002 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IDENTIFYING TARGETS FOR PREVENTING NEUROCOGNITIVE COMPLICATIONS IN YOUTH WITH T1D - PROJECT SUMMARY/ABSTRACT EARLY CHILDHOOD IS A CRITICAL TIME IN BRAIN DEVELOP | $631,348 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CAUSAL CONNECTIONS BETWEEN AXON GUIDANCE PROTEINS AND EARLY PROGRESSIVE KIDNEY FUNCTION DECLINE IN DIABETES - PROJECT SUMMARY/ABSTRACT END STAGE KIDNEY DISEASE | $611,231 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF THERMOGENIC ADIPOCYTE PROGRAM - PROJECT SUMMARY/ABSTRACT OBESITY AND ITS METABOLIC SEQUELAE ARE RAPIDLY INCREASING | $602,295 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | LIPOTOXICITY AND MAINTENANCE OF METABOLIC HEALTH - ABSTRACT LIPOTOXICITY IS AN IMPORTANT MECHANISM OF COMPLICATIONS IN TYPE 2 DIABETES, INCLUDING NON-ALCOHOLIC | $594,765 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GUT MICROBIAL FERMENTATION PRODUCTS OF MUSCLE-DERIVED LACTATE AS MEDIATORS OF EXERCISE AND METABOLISM - PROJECT SUMMARY/ABSTRACT THE GUT MICROBIOME MAKES SIGNIF | $593,332 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ALTERATIONS IN POST-RECEPTOR INSULIN SIGNALING IN DIABETES AND INSULIN RESISTANCE - ABSTRACT: THIS IS A REVISED GRANT APPLICATION ENTITLED “ALTERATIONS IN POST | $592,643 |
| 2025 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SIGNALING MECHANISMS THAT DETECT STRESS AND MAINTAIN HOMEOSTASIS | $543,652 |
| 2025 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MODULATING THE ADAPTIVE IMMUNE RESPONSE TO ENHANCE THE EFFICIENCY OF IN VIVO GENE EDITING IN MUSCLE - PROJECT SUMMARY DUCHENNE MUSCULAR DYSTROPHY (DMD) IS A DEB | $537,378 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNCOVERING CONSERVED LIPID HOMEOSTASIS MECHANISMS THAT MEDIATE LONGEVITY AFTER GERM CELL LOSS IN C. ELEGANS | $514,743 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ELUCIDATING AND TARGETING BETA-CELL SENESCENCE AND ITS SASP - ABSTRACT THIS PROPOSAL SEEKS TO ELUCIDATE THE MECHANISMS OF SS-CELL SENESCENCE, AN AGING HALLMARK, | $427,500 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | JOSLIN-BIDMC POSTBAC PROGRAM IN DIABETES AND METABOLISM - ABSTRACT THE UNITED STATES STRUGGLES TO CULTIVATE A BIOMEDICAL RESEARCH WORKFORCE THAT REFLECTS THE DI | $390,270 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | KIDNEY TRANSPLANT OUTCOMES AND APOL1 | $217,381 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PRECISION MONITORING: UNDERSTANDING MOMENTARY AFFECT, GLUCOSE, AND SELF-CARE BEHAVIORS IN ADOLESCENTS AND YOUNG ADULTS WITH TYPE 1 DIABETES - PROJECT SUMMARY/AB | $190,239 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF AN INTERVENTION TO TARGET DIABETES DEVICE USE THROUGH AN IDENTITY FRAMEWORK: ACCPTECH (ADAPT AND COMMIT TO CGM AND PUMP TECHNOLOGY) - PROJECT SUM | $188,784 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DRIVERS OF HUMAN INSULIN RESISTANCE AND SEX-SPECIFIC ALTERATIONS - PROJECT SUMMARY/ABSTRACT INSULIN RESISTANCE IS A MAJOR RISK FACTOR IN THE DEVELOPMENT OF TYPE | $150,583 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PANCREATIC BETA-CELL GLUCOSE TOXICITY AND MRNA TRANSLATION - ABSTRACT PANCREATIC Β-CELLS ARE SPECIALIZED TO CARRY OUT HIGH CAPACITY MRNA TRANSLATION THAT IS TIG | $90,000 |
| 2025 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | REPLICATION ANALYSIS TO IDENTIFY ACUTE MOLECULAR RESPONSES TO EXERCISE THAT LEAD TO CHRONIC TRAINING ADAPTATIONS - PROJECT SUMMARY/ABSTRACT THE MOLECULAR TRANSD | $85,500 |
| 2025 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INSULIN REGULATES AGING-ASSOCIATED GENES THROUGH CHROMATIN TOPOLOGY - PROJECT SUMMARY/ABSTRACT TITLE: INSULIN REGULATES AGING-ASSOCIATED GENES THROUGH CHROMATIN | $36,617 |
| 2025 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FEEDING DRIVES HSF1 TRANSCRIPTIONAL PROGRAMS REQUIRED FOR GLOBAL PROTEIN SYNTHESIS | -$329 |
| 2025 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | A PILOT CLINICAL TRIAL TO ASSESS FEASIBILITY, FACILITATORS AND BARRIERS OF CONTINUOUS GLUCOSE MONITORING IN ASIAN AMERICANS WITH TYPE 2 DIABETES - PROJECT SUMMA | -$16,013 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EPITRANSCRIPTOMICS IN HUMAN OBESITY AND TYPE 2 DIABETES - PROJECT SUMMARY DYSFUNCTION OF MULTIPLE METABOLIC CELLS CONTRIBUTE TO THE PATHOPHYSIOLOGY OF THE TWO M | $2,043,780 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIABETES AND ENDOCRINOLOGY RESEARCH CENTER | $1,706,072 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING, PREDICTING AND PREVENTING TYPE 2 DIABETES IN YOUTH, BOSTON CLINICAL CENTER (UPP STUDY) - PROJECT SUMMARY / ABSTRACT RISING OBESITY HAS LED TO AN | $1,036,368 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF RISK FACTORS FOR EXCESSIVE CARDIOVASCULAR DISEASES (CVD) FROM CIRCULATING AND CARDIOVASCULAR TISSUES OF PEOPLE WITH WELL-CONTROLLED CHRONIC | $1,009,308 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | USING EX VIVO, IN VIVO MODELS AND PATIENT MUTATIONS TO INTERROGATE PANCREATIC EXOCRINE-ENDOCRINE CROSS TALK - PROJECT SUMMARY TYPE 1 DIABETES AND ITS METABOLIC | $904,104 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EARLY MYOCARDIAL REMODELING AND PROGRESSIVE KIDNEY FUNCTION DECLINE IN TYPE 1 DIABETES - SUMMARY A LARGE PROPORTION OF THE EXCESS CVD MORBIDITY AND MORTALITY EX | $857,381 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRAINING GRANT IN DIABETES AND METABOLISM | $845,366 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMPROVING GLYCEMIA & REDUCING DIABETES DISTRESS IN ADOLESCENTS & YOUNG ADULTS WITH T1D - PROJECT SUMMARY/ABSTRACT ADOLESCENTS AND YOUNG ADULTS (AYA) WITH TYPE 1 | $780,793 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF CARDIOVASCULAR DISEASES (CVD) IN PEOPLE WITH LONG DURATION TYPE 1 DIABETES - ABSTRACT CARDIOVASCULAR DISEASE (CVD) IS THE MAJOR CAUSE OF MOR | $774,662 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL MECHANISMS FOR EXERCISE TRAINING EFFECTS ON GLUCOSE HOMEOSTASIS | $743,850 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSLATIONAL PROGRAMMING OF BETA-CELLS IN RESPONSE TO GLUCOSE TOXICITY - ABSTRACT CONTROL OF INSULIN BIOSYNTHESIS IN BETA-CELLS OCCURS PRIMARILY AT THE LEVEL O | $724,053 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PATERNAL CONTRIBUTIONS TO METABOLIC DISEASE IN OFFSPRING: ENVIRONMENT, EPIGENETICS, AND SPERM | $695,275 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLUCAGON PUMP THERAPY FOR POST-BARIATRIC HYPOGLYCEMIA: MERGING PHYSIOLOGY AND ENGINEERING - PROJECT SUMMARY/ABSTRACT BARIATRIC SURGERY IS A POTENT TREATMENT FO | $690,723 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXERCISE REGULATION OF GLUCOSE HOMEOSTASIS ADMINISTRATIVE SUPPLEMENT | $684,014 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DISSECTING THE THERMOGENIC ADIPOSE NICHE - PROJECT SUMMARY/ABSTRACT ADIPOSE TISSUE PLAYS A CRITICAL ROLE IN THE REGULATION OF WHOLE-BODY ENERGY METABOLISM, AND | $679,560 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENTAL GENES AND THE ORIGIN OF FAT | $670,261 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GUT MICROBIAL FERMENTATION PRODUCTS OF MUSCLE-DERIVED LACTATE AS MEDIATORS OF EXERCISE AND METABOLISM - PROJECT SUMMARY/ABSTRACT THE GUT MICROBIOME MAKES SIGNIF | $652,342 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CAUSAL CONNECTIONS BETWEEN AXON GUIDANCE PROTEINS AND EARLY PROGRESSIVE KIDNEY FUNCTION DECLINE IN DIABETES - PROJECT SUMMARY/ABSTRACT END STAGE KIDNEY DISEASE | $651,221 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INSULIN RECEPTOR STRUCTURE AND TURNOVER | $627,661 |
| 2024 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SIGNALING MECHANISMS THAT DETECT STRESS AND MAINTAIN HOMEOSTASIS | $618,000 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF THERMOGENIC ADIPOCYTE PROGRAM - PROJECT SUMMARY/ABSTRACT OBESITY AND ITS METABOLIC SEQUELAE ARE RAPIDLY INCREASING | $589,365 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | LIPOTOXICITY AND MAINTENANCE OF METABOLIC HEALTH - ABSTRACT LIPOTOXICITY IS AN IMPORTANT MECHANISM OF COMPLICATIONS IN TYPE 2 DIABETES, INCLUDING NON-ALCOHOLIC | $573,863 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ALTERATIONS IN POST-RECEPTOR INSULIN SIGNALING IN DIABETES AND INSULIN RESISTANCE - ABSTRACT: THIS IS A REVISED GRANT APPLICATION ENTITLED “ALTERATIONS IN POST | $568,937 |
| 2024 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | MODULATING THE ADAPTIVE IMMUNE RESPONSE TO ENHANCE THE EFFICIENCY OF IN VIVO GENE EDITING IN MUSCLE - PROJECT SUMMARY DUCHENNE MUSCULAR DYSTROPHY (DMD) IS A DEB | $537,378 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERACTION BETWEEN GENES, ENVIRONMENT, THE MICROBIOME AND METABOLOME IN TYPE 2 DIABETES AND METABOLIC SYNDROME | $526,942 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FIBROBLAST GROWTH FACTOR AND ENERGY METABOLISM | $526,732 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNCOVERING CONSERVED LIPID HOMEOSTASIS MECHANISMS THAT MEDIATE LONGEVITY AFTER GERM CELL LOSS IN C. ELEGANS | $525,247 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF PROGNOSTIC ALGORITHMS TO IDENTIFY SUBJECTS AT HIGH RISK OF ESKD IN TYPE 2 DIABETES - PROJECT SUMMARY/ABSTRACT WITH THE RISING PREVALENCE OF DIABE | $513,666 |
| 2024 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | IDENTIFICATION OF RETINOID-BINDING PROTEIN 3 (RBP3): A PROTECTIVE FACTOR AGAINST DIABETIC RETINOPATHY USING RETINA FROM PEOPLE WITH EXTREME DURATION | $471,383 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ELUCIDATING AND TARGETING BETA-CELL SENESCENCE AND ITS SASP - ABSTRACT THIS PROPOSAL SEEKS TO ELUCIDATE THE MECHANISMS OF SS-CELL SENESCENCE, AN AGING HALLMARK, | $410,400 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FUNCTIONAL VALIDATION OF GENE MODIFICATIONS THAT PROTECT BETA CELLS AGAINST AUTOIMMUNITY IDENTIFIED BY GENOME-WIDE CRISPR CAS9 SCREENING | $405,600 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | JOSLIN-BIDMC POSTBAC PROGRAM IN DIABETES AND METABOLISM - ABSTRACT THE UNITED STATES STRUGGLES TO CULTIVATE A BIOMEDICAL RESEARCH WORKFORCE THAT REFLECTS THE DI | $392,258 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING THE ROLE OF THE COMPLEMENT PROTEOME IN PROGRESSIVE DIABETIC KIDNEY DISEASE | $351,902 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IDENTIFYING TARGETS FOR PREVENTING NEUROCOGNITIVE COMPLICATIONS IN YOUTH WITH T1D - PROJECT SUMMARY/ABSTRACT EARLY CHILDHOOD IS A CRITICAL TIME IN BRAIN DEVELOP | $320,972 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF AN INTERVENTION TO TARGET DIABETES DEVICE USE THROUGH AN IDENTITY FRAMEWORK: ACCPTECH (ADAPT AND COMMIT TO CGM AND PUMP TECHNOLOGY) - PROJECT SUM | $190,284 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PRECISION MONITORING: UNDERSTANDING MOMENTARY AFFECT, GLUCOSE, AND SELF-CARE BEHAVIORS IN ADOLESCENTS AND YOUNG ADULTS WITH TYPE 1 DIABETES - PROJECT SUMMARY/AB | $190,263 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | KIDNEY TRANSPLANT OUTCOMES AND APOL1 | $170,000 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PANCREATIC BETA-CELL GLUCOSE TOXICITY AND MRNA TRANSLATION - ABSTRACT PANCREATIC Β-CELLS ARE SPECIALIZED TO CARRY OUT HIGH CAPACITY MRNA TRANSLATION THAT IS TIG | $91,500 |
| 2024 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERROGATING THE ROLE OF M6A MRNA METHYLATION IN THE AGING OF THE ?-CELL AND DIABETES - PROJECT SUMMARY ALTHOUGH THE ETIOPATHOGENESIS OF TYPE 1 (T1D) AND TYPE | $90,000 |
| 2024 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | INSULIN REGULATES AGING-ASSOCIATED GENES THROUGH CHROMATIN TOPOLOGY - PROJECT SUMMARY/ABSTRACT TITLE: INSULIN REGULATES AGING-ASSOCIATED GENES THROUGH CHROMATIN | $37,463 |
| 2024 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | IDENTIFICATION OF PATHWAYS REQUIRED FOR HIGH GLUCOSE-INDUCED OXIDATIVE STRESS ASSOCIATED WITH DIABETIC EMBRYOPATHY BY CRISPR-GENERATED MUTATION SCREEN | -$1,063 |
| 2024 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | ANIMAL STUDIES INVESTIGATING MOLECULAR TRANSDUCERS OF PHYSICAL ACTIVITY | -$6,628 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISM OF ENDOCYTIC TRAFFICKING OF CHOLESTEROL | -$62,919 |
| 2024 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | POST-DPP FOLLOW-UP STUDY | -$205,245 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIABETES AND ENDOCRINOLOGY RESEARCH CENTER | $1,703,578 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | USING EX VIVO, IN VIVO MODELS AND PATIENT MUTATIONS TO INTERROGATE PANCREATIC EXOCRINE-ENDOCRINE CROSS TALK - PROJECT SUMMARY TYPE 1 DIABETES AND ITS METABOLIC | $919,535 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMPROVING GLYCEMIA & REDUCING DIABETES DISTRESS IN ADOLESCENTS & YOUNG ADULTS WITH T1D - PROJECT SUMMARY/ABSTRACT ADOLESCENTS AND YOUNG ADULTS (AYA) WITH TYPE 1 | $792,319 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF CARDIOVASCULAR DISEASES (CVD) IN PEOPLE WITH LONG DURATION TYPE 1 DIABETES - ABSTRACT CARDIOVASCULAR DISEASE (CVD) IS THE MAJOR CAUSE OF MOR | $775,846 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GLUCAGON PUMP THERAPY FOR POST-BARIATRIC HYPOGLYCEMIA: MERGING PHYSIOLOGY AND ENGINEERING - PROJECT SUMMARY/ABSTRACT BARIATRIC SURGERY IS A POTENT TREATMENT FO | $745,625 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRAINING GRANT IN DIABETES AND METABOLISM | $740,757 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PATERNAL CONTRIBUTIONS TO METABOLIC DISEASE IN OFFSPRING: ENVIRONMENT, EPIGENETICS, AND SPERM | $733,550 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF PROGNOSTIC ALGORITHMS TO IDENTIFY SUBJECTS AT HIGH RISK OF ESKD IN TYPE 2 DIABETES - PROJECT SUMMARY/ABSTRACT WITH THE RISING PREVALENCE OF DIABE | $725,018 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXERCISE REGULATION OF GLUCOSE HOMEOSTASIS ADMINISTRATIVE SUPPLEMENT | $724,625 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DISSECTING THE THERMOGENIC ADIPOSE NICHE - PROJECT SUMMARY/ABSTRACT ADIPOSE TISSUE PLAYS A CRITICAL ROLE IN THE REGULATION OF WHOLE-BODY ENERGY METABOLISM, AND | $714,937 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EARLY MYOCARDIAL REMODELING AND PROGRESSIVE KIDNEY FUNCTION DECLINE IN TYPE 1 DIABETES - SUMMARY A LARGE PROPORTION OF THE EXCESS CVD MORBIDITY AND MORTALITY EX | $708,852 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENTAL GENES AND THE ORIGIN OF FAT | $700,075 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CAUSAL CONNECTIONS BETWEEN AXON GUIDANCE PROTEINS AND EARLY PROGRESSIVE KIDNEY FUNCTION DECLINE IN DIABETES - PROJECT SUMMARY/ABSTRACT END STAGE KIDNEY DISEASE | $681,743 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INSULIN RECEPTOR STRUCTURE AND TURNOVER | $669,581 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GUT MICROBIAL FERMENTATION PRODUCTS OF MUSCLE-DERIVED LACTATE AS MEDIATORS OF EXERCISE AND METABOLISM - PROJECT SUMMARY/ABSTRACT THE GUT MICROBIOME MAKES SIGNIF | $634,993 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF THERMOGENIC ADIPOCYTE PROGRAM - PROJECT SUMMARY/ABSTRACT OBESITY AND ITS METABOLIC SEQUELAE ARE RAPIDLY INCREASING | $623,366 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL MECHANISMS FOR EXERCISE TRAINING EFFECTS ON GLUCOSE HOMEOSTASIS | $615,484 |
| 2023 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNCOVERING CONSERVED LIPID HOMEOSTASIS MECHANISMS THAT MEDIATE LONGEVITY AFTER GERM CELL LOSS IN C. ELEGANS | $599,011 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | LIPOTOXICITY AND MAINTENANCE OF METABOLIC HEALTH - ABSTRACT LIPOTOXICITY IS AN IMPORTANT MECHANISM OF COMPLICATIONS IN TYPE 2 DIABETES, INCLUDING NON-ALCOHOLIC | $594,331 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ALTERATIONS IN POST-RECEPTOR INSULIN SIGNALING IN DIABETES AND INSULIN RESISTANCE - ABSTRACT: THIS IS A REVISED GRANT APPLICATION ENTITLED “ALTERATIONS IN POST | $589,410 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FIBROBLAST GROWTH FACTOR AND ENERGY METABOLISM | $548,678 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERACTION BETWEEN GENES, ENVIRONMENT, THE MICROBIOME AND METABOLOME IN TYPE 2 DIABETES AND METABOLIC SYNDROME | $548,197 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF BROWN FAT-DERIVED SPECIALIZED PRO-RESOLVING LIPID MEDIATORS IN INFLAMMATION AND METABOLISM | $535,507 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS FOR IMPAIRED ADAPTATION TO AEROBIC EXERCISE WITH METABOLIC DISEASE | $528,727 |
| 2023 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SIGNALING MECHANISMS THAT DETECT STRESS AND MAINTAIN HOMEOSTASIS | $516,971 |
| 2023 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | IDENTIFICATION OF RETINOID-BINDING PROTEIN 3 (RBP3): A PROTECTIVE FACTOR AGAINST DIABETIC RETINOPATHY USING RETINA FROM PEOPLE WITH EXTREME DURATION | $479,838 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ELUCIDATING AND TARGETING BETA-CELL SENESCENCE AND ITS SASP - ABSTRACT THIS PROPOSAL SEEKS TO ELUCIDATE THE MECHANISMS OF SS-CELL SENESCENCE, AN AGING HALLMARK, | $426,979 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FUNCTIONAL VALIDATION OF GENE MODIFICATIONS THAT PROTECT BETA CELLS AGAINST AUTOIMMUNITY IDENTIFIED BY GENOME-WIDE CRISPR CAS9 SCREENING | $422,500 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING THE ROLE OF THE COMPLEMENT PROTEOME IN PROGRESSIVE DIABETIC KIDNEY DISEASE | $407,463 |
| 2023 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | ANIMAL STUDIES INVESTIGATING MOLECULAR TRANSDUCERS OF PHYSICAL ACTIVITY | $394,305 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | A PILOT STUDY OF FENOFIBRATE TO PREVENT KIDNEY FUNCTION LOSS IN TYPE 1 DIABETES - SUMMARY DESPITE IMPROVEMENTS IN THE PAST 20 YEARS IN GLYCEMIC AND BLOOD PRESSU | $341,580 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | KIDNEY TRANSPLANT OUTCOMES AND APOL1 | $324,000 |
| 2023 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | A PILOT CLINICAL TRIAL TO ASSESS FEASIBILITY, FACILITATORS AND BARRIERS OF CONTINUOUS GLUCOSE MONITORING IN ASIAN AMERICANS WITH TYPE 2 DIABETES - PROJECT SUMMA | $213,125 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PRECISION MONITORING: UNDERSTANDING MOMENTARY AFFECT, GLUCOSE, AND SELF-CARE BEHAVIORS IN ADOLESCENTS AND YOUNG ADULTS WITH TYPE 1 DIABETES - PROJECT SUMMARY/AB | $191,869 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING, PREDICTING AND PREVENTING TYPE 2 DIABETES IN YOUTH, BOSTON CLINICAL CENTER (UPP STUDY) - PROJECT SUMMARY / ABSTRACT RISING OBESITY HAS LED TO AN | $166,817 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERROGATING THE ROLE OF M6A MRNA METHYLATION IN THE AGING OF THE ?-CELL AND DIABETES - PROJECT SUMMARY ALTHOUGH THE ETIOPATHOGENESIS OF TYPE 1 (T1D) AND TYPE | $90,000 |
| 2023 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | ROLE OF BRADYKININ RECEPTOR 2 IN TPA STROKE THERAPY | -$1,458 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERROGATION OF DYNAMIC RNA MODIFICATIONS IN BETA CELLS IN TYPE 1 DIABETES | -$32,607 |
| 2023 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | USE OF CONTINUOUS GLUCOSE MONITORING WITH AUTOMATED CLINICAL DECISION SUPPORT TO REDUCE HYPOGLYCEMIA IN OLDER ADULTS WITH TYPE 1 DIABETES | -$33,872 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DIABETES AND ENDOCRINOLOGY RESEARCH CENTER | $1,698,590 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | USING EX VIVO, IN VIVO MODELS AND PATIENT MUTATIONS TO INTERROGATE PANCREATIC EXOCRINE-ENDOCRINE CROSS TALK - PROJECT SUMMARY TYPE 1 DIABETES AND ITS METABOLIC | $958,436 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | RIBOSOME HETEROGENEITY AS A MECHANISM FOR METABOLIC REGULATION | $950,451 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CHARACTERIZATION OF CARDIOVASCULAR DISEASES (CVD) IN PEOPLE WITH LONG DURATION TYPE 1 DIABETES - ABSTRACT CARDIOVASCULAR DISEASE (CVD) IS THE MAJOR CAUSE OF MOR | $850,868 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EARLY MYOCARDIAL REMODELING AND PROGRESSIVE KIDNEY FUNCTION DECLINE IN TYPE 1 DIABETES - SUMMARY A LARGE PROPORTION OF THE EXCESS CVD MORBIDITY AND MORTALITY EX | $821,720 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CAUSAL CONNECTIONS BETWEEN AXON GUIDANCE PROTEINS AND EARLY PROGRESSIVE KIDNEY FUNCTION DECLINE IN DIABETES - PROJECT SUMMARY/ABSTRACT END STAGE KIDNEY DISEASE | $769,689 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PATERNAL CONTRIBUTIONS TO METABOLIC DISEASE IN OFFSPRING: ENVIRONMENT, EPIGENETICS, AND SPERM | $741,030 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DISSECTING THE THERMOGENIC ADIPOSE NICHE - PROJECT SUMMARY/ABSTRACT ADIPOSE TISSUE PLAYS A CRITICAL ROLE IN THE REGULATION OF WHOLE-BODY ENERGY METABOLISM, AND | $739,622 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMPROVING GLYCEMIA & REDUCING DIABETES DISTRESS IN ADOLESCENTS & YOUNG ADULTS WITH T1D - PROJECT SUMMARY/ABSTRACT ADOLESCENTS AND YOUNG ADULTS (AYA) WITH TYPE 1 | $704,934 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF PROGNOSTIC ALGORITHMS TO IDENTIFY SUBJECTS AT HIGH RISK OF ESKD IN TYPE 2 DIABETES - PROJECT SUMMARY/ABSTRACT WITH THE RISING PREVALENCE OF DIABE | $703,006 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INSULIN RECEPTOR STRUCTURE AND TURNOVER | $680,184 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRAINING GRANT IN DIABETES AND METABOLISM | $673,276 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXERCISE REGULATION OF GLUCOSE HOMEOSTASIS ADMINISTRATIVE SUPPLEMENT | $654,517 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRANSCRIPTIONAL AND EPIGENETIC REGULATION OF THERMOGENIC ADIPOCYTE PROGRAM - PROJECT SUMMARY/ABSTRACT OBESITY AND ITS METABOLIC SEQUELAE ARE RAPIDLY INCREASING | $632,230 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENTAL GENES AND THE ORIGIN OF FAT | $625,298 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL MECHANISMS FOR EXERCISE TRAINING EFFECTS ON GLUCOSE HOMEOSTASIS | $615,484 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ALTERATIONS IN POST-RECEPTOR INSULIN SIGNALING IN DIABETES AND INSULIN RESISTANCE - ABSTRACT: THIS IS A REVISED GRANT APPLICATION ENTITLED “ALTERATIONS IN POST | $595,695 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | GUT MICROBIAL FERMENTATION PRODUCTS OF MUSCLE-DERIVED LACTATE AS MEDIATORS OF EXERCISE AND METABOLISM - PROJECT SUMMARY/ABSTRACT THE GUT MICROBIOME MAKES SIGNIF | $588,659 |
| 2022 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SIGNALING MECHANISMS THAT DETECT STRESS AND MAINTAIN HOMEOSTASIS | $576,830 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FIBROBLAST GROWTH FACTOR AND ENERGY METABOLISM | $575,674 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERACTION BETWEEN GENES, ENVIRONMENT, THE MICROBIOME AND METABOLOME IN TYPE 2 DIABETES AND METABOLIC SYNDROME | $548,197 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF BROWN FAT-DERIVED SPECIALIZED PRO-RESOLVING LIPID MEDIATORS IN INFLAMMATION AND METABOLISM | $536,943 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS FOR IMPAIRED ADAPTATION TO AEROBIC EXERCISE WITH METABOLIC DISEASE | $528,727 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UNDERSTANDING THE ROLE OF THE COMPLEMENT PROTEOME IN PROGRESSIVE DIABETIC KIDNEY DISEASE | $516,658 |
| 2022 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | ANIMAL STUDIES INVESTIGATING MOLECULAR TRANSDUCERS OF PHYSICAL ACTIVITY | $486,226 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF IGF-1 AND INSULIN RECEPTORS BETA-CELL SURVIVAL | $465,832 |
| 2022 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | IDENTIFICATION OF RETINOID-BINDING PROTEIN 3 (RBP3): A PROTECTIVE FACTOR AGAINST DIABETIC RETINOPATHY USING RETINA FROM PEOPLE WITH EXTREME DURATION | $465,441 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FUNCTIONAL VALIDATION OF GENE MODIFICATIONS THAT PROTECT BETA CELLS AGAINST AUTOIMMUNITY IDENTIFIED BY GENOME-WIDE CRISPR CAS9 SCREENING | $422,500 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ELUCIDATING AND TARGETING BETA-CELL SENESCENCE AND ITS SASP - ABSTRACT THIS PROPOSAL SEEKS TO ELUCIDATE THE MECHANISMS OF SS-CELL SENESCENCE, AN AGING HALLMARK, | $384,257 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | CARDIAC AUTOIMMUNITY AS A MEDIATOR OF CARDIOVASCULAR OUTCOMES IN TYPE 1 DIABETES | $370,243 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | A PILOT STUDY OF FENOFIBRATE TO PREVENT KIDNEY FUNCTION LOSS IN TYPE 1 DIABETES - SUMMARY DESPITE IMPROVEMENTS IN THE PAST 20 YEARS IN GLYCEMIC AND BLOOD PRESSU | $331,750 |
| 2022 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS OF EXERCISE EFFECTS IN OBESE HUMANS: SEX-SPECIFIC REGULATION OF NOVEL ADIPOSE TISSUE FUNCTION | $300,182 |
| 2022 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | IDENTIFYING METABOLIC MECHANISMS THAT REGULATE APPETITE AND FOODINTAKE - PROJECT SUMMARY UNDERSTANDING HOW APPETITE AND FOOD CONSUMPTION ARE REGULATED IS CRITI | $256,701 |
| 2022 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | A PILOT CLINICAL TRIAL TO ASSESS FEASIBILITY, FACILITATORS AND BARRIERS OF CONTINUOUS GLUCOSE MONITORING IN ASIAN AMERICANS WITH TYPE 2 DIABETES - PROJECT SUMMA | $255,563 |
| 2021 | National Institutes of Health | Grant or other assistance | MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH 93.307 | DIABETES AND ENDOCRINOLOGY RESEARCH CENTER | $1,606,303 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | RIBOSOME HETEROGENEITY AS A MECHANISM FOR METABOLIC REGULATION | $814,408 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PATERNAL CONTRIBUTIONS TO METABOLIC DISEASE IN OFFSPRING: ENVIRONMENT, EPIGENETICS, AND SPERM | $801,134 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENT OF PROGNOSTIC ALGORITHMS TO IDENTIFY SUBJECTS AT HIGH RISK OF ESKD IN TYPE 2 DIABETES - PROJECT SUMMARY/ABSTRACT WITH THE RISING PREVALENCE OF DIABE | $771,168 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | IMPROVING GLYCEMIA & REDUCING DIABETES DISTRESS IN ADOLESCENTS & YOUNG ADULTS WITH T1D - PROJECT SUMMARY/ABSTRACT ADOLESCENTS AND YOUNG ADULTS (AYA) WITH TYPE 1 | $725,398 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INSULIN RECEPTOR STRUCTURE AND TURNOVER | $690,972 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | TRAINING GRANT IN DIABETES AND METABOLISM | $683,439 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | EXERCISE REGULATION OF GLUCOSE HOMEOSTASIS ADMINISTRATIVE SUPPLEMENT | $654,517 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DEVELOPMENTAL GENES AND THE ORIGIN OF FAT | $629,531 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | NOVEL MECHANISMS FOR EXERCISE TRAINING EFFECTS ON GLUCOSE HOMEOSTASIS | $615,484 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | FIBROBLAST GROWTH FACTOR AND ENERGY METABOLISM | $606,855 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS FOR IMPAIRED ADAPTATION TO AEROBIC EXERCISE WITH METABOLIC DISEASE | $550,129 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ALTERATIONS IN POST-RECEPTOR INSULIN SIGNALING IN DIABETES AND INSULIN RESISTANCE - ABSTRACT: THIS IS A REVISED GRANT APPLICATION ENTITLED “ALTERATIONS IN POST | $549,033 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF BROWN FAT-DERIVED SPECIALIZED PRO-RESOLVING LIPID MEDIATORS IN INFLAMMATION AND METABOLISM | $548,304 |
| 2021 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | INTERACTION BETWEEN GENES, ENVIRONMENT, THE MICROBIOME AND METABOLOME IN TYPE 2 DIABETES AND METABOLIC SYNDROME | $548,197 |
| 2021 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SIGNALING MECHANISMS THAT DETECT STRESS AND MAINTAIN HOMEOSTASIS | $496,164 |
State business registration
- JOSLIN DIABETES CENTER, INC. MA, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
The same business name in the same state, from the state’s official registry data.
Patents
37 US patents filed in the last 20 years.
- Joslin Diabetes Center 37 patents, 2010-04-13 to 2026-03-24 FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12583916 | Methods to improve glucose tolerance in a subject by administering an antibody that binds to extracellular human metallothionein 1A (MT1A) | 2026-03-24 | PTBLXML, file of 2026-03-24 |
| US 12559746 | Targeting micro-RNAs for exosomal delivery or cellular retention | 2026-02-24 | PTBLXML, file of 2026-02-24 |
| US 12545895 | Protection of beta cells from immune attack | 2026-02-10 | PTBLXML, file of 2026-02-10 |
| US 12161463 | Prevention of post-bariatric hypoglycemia using a novel glucose prediction algorithm and mini-dose stable glucagon | 2024-12-10 | PVGPATDIS, file of 2026-04-10 |
| US 12005039 | Methods and compositions relating to lipokines for treating metabolic disorders | 2024-06-11 | PVGPATDIS, file of 2026-04-10 |
| US 11885813 | Methods of diagnosing and predicting renal disease | 2024-01-30 | PVGPATDIS, file of 2026-04-10 |
| US 11866488 | Compositions comprising an anti-metallothionein antibody and a pancreatic cell targeting moiety | 2024-01-09 | PVGPATDIS, file of 2026-04-10 |
| US 11708561 | Protection of beta cells from immune attack | 2023-07-25 | PVGPATDIS, file of 2026-04-10 |
| US 11519008 | Exosome delivery system | 2022-12-06 | PVGPATDIS, file of 2026-04-10 |
| US 11433042 | Methods and compositions for treating metabolic disorders | 2022-09-06 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
6 US trademarks, 3 live.
- Joslin Diabetes Center, Inc. 6 marks, MA EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| JOSLIN KIDNEY PANEL | 98749057 | 2024-09-13 | Abandoned | TRTDXFAP, file of 2026-10-24 |
| DRAG 'N COOK | 85978190 | 2011-10-26 | Registration cancelled | TRCFECO2, file of 2024-03-27 |
| DRAG 'N COOK | 85456810 | 2011-10-26 | Registration cancelled | TRCFECO2, file of 2024-03-27 |
| J JOSLIN DIABETES CENTER | 78505558 | 2004-10-25 | Registered and renewed | TRTDXFAP, file of 2026-09-09 |
| JOSLIN | 76182220 | 2000-12-18 | Registered and renewed | TRCFECO2, file of 2024-03-27 |
| DO IT | 76177657 | 2000-12-07 | Registered and renewed | TRCFECO2, file of 2024-03-27 |
The newest marks of the trademark owners above, matched to this record by name (and state).
In the news
4,439 news articles name this organization (February 2015 to November 2026); the latest 10:
- New global Mouth-to-Body Health Institute aims to turn oral-systemic science into better prevention and care - Dental Industry News
zenopa.com, November 6, 2026 - Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology to Its Consortium
prnewswire.com, November 5, 2026 - How proteomics is transforming pharmaceutical development
news-medical.net, October 29, 2026 - Dana-Farber and Beth Israel Break Ground on $1.68 Billion, 300-Bed Boston Cancer Hospital Opening in 2031
medicaldaily.com, October 22, 2026 - ENR Top 600: AI Boom Tests Talent Pipelines
enr.com, October 21, 2026 - Boston is getting a new cancer hospital. Here's what Dana-Farber's $1.7B project means for patients
wbur.org, October 21, 2026 - Dana-Farber Breaks Ground on Lavine Bekenstein Cancer Hospital
newswise.com, October 19, 2026 - Dana-Farber, Beth Israel cancer hospital construction begins
bostonglobe.com, October 19, 2026 - twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes
manilatimes.net, October 16, 2026 - Beth Israel Lahey Health names Peter Shorett as new CEO
bostonglobe.com, October 8, 2026
News article metadata and links: The GDELT Project (https://www.gdeltproject.org/). Matched by: Exact name match: "joslin diabetes center". A shared name is not proof of the same organization; how the matching works. Most in the news.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Joslin Diabetes Center, Inc. | MA | State business registries | name and state |
| Business registration | JOSLIN DIABETES CENTER INC | MA | State business registries | name and state |
| Contractor | JOSLIN DIABETES CENTER INC | MA | Nonprofit contractors (Form 990) | name and state |
| Plan sponsor | JOSLIN DIABETES CENTER, INC. | MA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Federal award recipient | JOSLIN DIABETES CENTER, INC. | MA | Federal spending (USAspending) | name and state |
| Lobbying client | JOSLIN DIABETES CENTER | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | JOSLIN DIABETES CENTER | MA | Federal lobbying (LDA) | name and state |
| Payment recipient | JOSLIN DIABETES CENTER | MA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Joslin Diabetes Center, Inc. | MA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | JOSLIN DIABETES CENTER INC | MA | Open Payments (drug and device company payments) | name and state |
| Payment recipient | JOSLIN DIABETES CENTER, INC | MA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Joslin Diabetes Center | MA | Patents (USPTO) | name and state |
| Trademark owner | Joslin Diabetes Center, Inc. | MA | Trademarks (USPTO) | name and state |
| Wikipedia article | Joslin Diabetes Center | Wikipedia (English) | EXACT: the same IRS employer identification number (EIN) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
NTEE code Specifically Named Diseases, MA first:
- ALS THERAPY ALLIANCE INC MA
- MATTHEW NAGLE SPINAL INJURY MA
- MIRACLES FROM MOODY FOUNDATION INC MA
- L I F E INC LIVING IS FOR THE MA
- THE CURE FOR DIABETES INC MA
- MAKE A WISH FOUNDATION OF WESTERN MA
- MASSACHUSETTS ME-CFS & FM ASSOCIATION INC MA
- PREVENT AUTISM NOW MA
- MIKE PAGLIARULO FOUNDATION INC MA
- SICKLE CELL DISEASE INTERNATIONAL MA
In other datasets, the same topic (Health) in MA:
- Lobbying client: 1776 HEALTHCARE (Federal lobbying (LDA))
Interests: Specifically Named Diseases · girls_boys:boys · girls_boys:girls · men:issues · science:research_education · women:issues · Health
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Census Tract 9818, Suffolk County, Massachusetts, place (city or town) Boston, MA, county Suffolk County, MA, state Massachusetts; placed by its ZIP code (county and tract) and city name (place). The tract is the tract holding most of the record's ZIP code (FURP does not geocode street addresses).
- TABB MD KEVIN was paid $4,734,371, 48.6 times the median household income in Boston, MA ($97,344), where 16.6% of residents live in poverty.
- Revenue of $77,259,482 is $116 per resident of Boston, MA (population 666,442).
- That revenue equals 0.28% of all household income in Boston, MA (283,374 households at the median $97,344, about $27,584,758,656).
- 499 employees is 0.7 per 1,000 residents of Boston, MA.
| Measure | Census tract Census Tract 9818, Suffolk County, Massachusetts | Place (city or town) Boston, MA | County Suffolk County, MA | State Massachusetts |
|---|---|---|---|---|
| Population B01003 | 20 | 666,442 | 785,121 | 7,044,056 |
| Population, 2020 census P1 | 23 | 675,647 | 797,936 | 7,029,917 |
| Median age B01002 | 72.5 | 33.3 | 33.9 | 40.0 |
| Under 18 B01001 | 0.0% | 15.1% | 16.0% | 19.4% |
| 65 and over B01001 | 100.0% | 13.0% | 13.3% | 17.9% |
| Households B11001 | 16 | 283,374 | 327,167 | 2,785,042 |
| Foreign born B05002 | 50.0% | 27.8% | 29.8% | 18.0% |
| Median household income B19013 | $-666,666,666 | $97,344 | $95,631 | $103,960 |
| Median family income B19113 | $-666,666,666 | $116,436 | $112,072 | $131,675 |
| Per capita income B19301 | $681,885 | $61,698 | $58,636 | $57,897 |
| Poverty rate B17001 | 0.0% | 16.6% | 16.2% | 10.0% |
| Unemployment rate B23025 | 0.0% | 6.1% | 6.3% | 5.2% |
| Civilian labor force B23025 | 10 | 402,354 | 468,636 | 3,911,446 |
| Mean commute (minutes) B08013 | - | 30.3 | 30.9 | 29.1 |
| Bachelor's degree or higher B15003 | 100.0% | 54.9% | 50.6% | 47.3% |
| Housing units B25001 | 16 | 310,625 | 357,290 | 3,030,406 |
| Owner-occupied B25003 | 100.0% | 35.7% | 36.5% | 62.5% |
| Renters B25003 | 0.0% | 64.3% | 63.5% | 37.5% |
| Median home value B25077 | $-666,666,666 | $731,700 | $705,800 | $562,100 |
| Median gross rent B25064 | $-666,666,666 | $2,147 | $2,129 | $1,762 |
| White, not Hispanic B03002 | 50.0% | 44.1% | 43.6% | 66.6% |
| Black B03002 | 0.0% | 19.3% | 17.1% | 6.4% |
| Hispanic or Latino B03002 | 0.0% | 19.3% | 23.2% | 13.3% |
| Asian B03002 | 50.0% | 10.3% | 9.2% | 7.3% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.6% a year earlier); per capita personal income $98,700 in 2025, up 27% in five years (+2.3% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Census Tract 9818, Suffolk County, Massachusetts.
Comments